Pyloric Stenosis (Infantile Hypertrophic Pyloric Stenosis)

1. Clinical Overview

Summary

Infantile Hypertrophic Pyloric Stenosis (IHPS) is the most common cause of gastric outlet obstruction in infants, characterised by progressive hypertrophy and hyperplasia of the pyloric smooth muscle causing functional obstruction. [1] It classically presents at 2-8 weeks of age with projectile, non-bilious vomiting in an otherwise healthy infant who remains hungry after vomiting—a distinguishing feature from other causes of infant vomiting. [2] The diagnosis is confirmed by ultrasound demonstrating a thickened pyloric muscle (> 3mm) and elongated pyloric channel (> 15mm), with sensitivity and specificity exceeding 95%. [3,4] Treatment involves careful preoperative correction of the characteristic hypochloraemic, hypokalaemic metabolic alkalosis, followed by Ramstedt pyloromyotomy, which has a cure rate exceeding 99%. [1,5]

Key Facts

• Incidence: 1.5-4.0 per 1,000 live births; highest in Caucasians (3.0/1,000), lower in African (0.7/1,000) and Asian (1.5/1,000) populations. [6,7]
• Peak Age: 3-6 weeks postnatal age (range 2-12 weeks). Preterm infants present later at similar post-conceptional age. [2]
• Sex Predominance: Male to female ratio 4-5:1. Firstborn males at highest risk. [6,8]
• Inheritance: Multifactorial polygenic inheritance. If mother affected, offspring risk 10-20%; if father affected, risk 5%. [8]
• Classic Metabolic Disturbance: Hypokalaemic, hypochloraemic metabolic alkalosis with paradoxical aciduria. [9]
• Ultrasound Criteria: Pyloric muscle thickness ≥3mm, pyloric length ≥15-17mm, pyloric diameter ≥13mm. [3,4]
• Cure Rate: Greater than 99% with pyloromyotomy; mortality less than 0.1% in developed countries. [1,5]
• Historical Milestone: Conrad Ramstedt first described pyloromyotomy in 1912, reducing mortality from > 50% to less than 1%.

Clinical Pearls

The Metabolic Signature: Progressive loss of gastric HCl causes metabolic alkalosis and hypochloraemia. Volume depletion triggers aldosterone release, promoting renal Na+ retention in exchange for K+ and H+ excretion. This creates the characteristic "paradoxical aciduria"—an alkalotic patient excreting acidic urine. [9] As alkalosis worsens, compensatory hypoventilation may cause respiratory depression and apnoea, particularly concerning during anaesthesia. [10]

Surgery is NOT an Emergency: Never take a dehydrated, alkalotic infant to theatre. Pyloric stenosis is a medical emergency requiring metabolic stabilisation first—surgery can safely wait 24-48 hours. [1,11] The metabolic derangement poses greater anaesthetic and perioperative risk than the obstruction itself. Target chloride > 100 mmol/L, potassium > 3.5 mmol/L, pH less than 7.45, and urine output > 1 mL/kg/hr before surgery. [11]

The Hungry Baby Sign: Unlike intestinal obstruction where infants appear systemically unwell and refuse feeds, IHPS infants are characteristically ravenous after vomiting and eagerly demand to feed again immediately. This pathognomonic feature reflects gastric (not intestinal) obstruction—the infant is genuinely hungry. [2]

Olive Palpation Technique: The pyloric "olive" is palpable in 60-85% of cases by experienced examiners. [12,13] Optimal technique: feed the baby to relax the abdomen and distend the stomach, stand on the baby's left side, use your left hand with flexed fingers, palpate deeply in the right upper quadrant just lateral to the rectus abdominis, feeling for a firm, mobile, 1.5-2cm "olive" that slips under your fingers. A palpable olive is diagnostic and may obviate the need for ultrasound. [12]

The Macrolide-Pyloric Stenosis Link: Erythromycin exposure in the first 2 weeks of life increases IHPS risk 8-10 fold; azithromycin confers a 3-fold increase. [14,15] Macrolides act as motilin receptor agonists, potentially stimulating pyloric smooth muscle hypertrophy. Maternal macrolide use in late pregnancy or during breastfeeding also increases infant risk 2-3 fold. [14,15] Use macrolides judiciously in young infants; counsel parents about warning signs if prescribed.

---

2. Epidemiology

Incidence and Demographics

Global Incidence

• Overall incidence: 1.5-4.0 per 1,000 live births with significant geographic and ethnic variation. [6,7]
• Caucasian populations: 2.0-4.0/1,000 (highest rates in Northern European descent).
• Hispanic populations: 1.8/1,000.
• Asian populations: 1.5/1,000.
• African populations: 0.7/1,000 (lowest rates).

Age and Sex Distribution

• Peak incidence: 3-6 weeks postnatal age (median 38 days). [2]
• 95% of cases present between 2-12 weeks; rare after 5 months.
• Male predominance: 4-5:1 ratio (80-85% are male). [6,8]
• Firstborn infants: 1.5-2 times higher risk than subsequent siblings. [8]

Temporal Trends

• Seasonal variation: Slight increase in autumn/winter births, possibly related to infant feeding patterns and viral gastroenteritis mimicking early symptoms. [6]
• Geographic clustering: Higher rates in certain regions may reflect genetic founder effects.

Risk Factors

Comprehensive meta-analysis of perinatal risk factors identifies multiple independent associations: [8]

The Macrolide-IHPS Association

Discovery and Mechanism

• Epidemiological link first reported in 1999; strengthened by multiple subsequent studies. [14,15]
• Macrolides are motilin receptor agonists → stimulate gastric and pyloric smooth muscle contraction → may trigger hypertrophy in genetically susceptible infants. [14]
• Critical exposure window: First 2 weeks of life (period of postnatal pyloric development). [15]

Magnitude of Risk [14,15]

• Erythromycin (first 2 weeks): OR 8-10 (95% CI 4.5-15.6).
• Azithromycin (first 2 weeks): OR 3.0 (95% CI 1.7-5.6).
• Maternal use in late pregnancy: OR 2.8 (95% CI 1.5-4.9).
• Maternal use during breastfeeding: OR 2.5 (95% CI 1.4-4.3).

Clinical Implications

• Avoid macrolides in first 6 weeks unless compelling indication (e.g., pertussis prophylaxis—where benefit outweighs risk).
• If macrolides essential, counsel parents about IHPS symptoms: progressive non-bilious vomiting, hungry infant, weight loss.
• Consider alternative antibiotics when appropriate.

Genetic and Environmental Factors

Genetic Contribution [8]

• Twin studies: Concordance 25-40% in monozygotic twins, 5% in dizygotic twins.
• Polygenic inheritance model best fits epidemiological data.
• Candidate genes: Studies suggest roles for neuronal nitric oxide synthase (nNOS), vasoactive intestinal peptide (VIP), and apelin signalling—all involved in pyloric smooth muscle relaxation.

Environmental Factors [16]

• Pesticide exposure: Maternal exposure to atrazine and other organophosphates during pregnancy associated with 2-3 fold increased IHPS risk in some US cohort studies.
• Prostaglandin E exposure: Infants treated with prostaglandin E1 for ductal-dependent congenital heart disease have increased IHPS incidence (mechanism: smooth muscle effects).

---

3. Pathophysiology

Step 1: Normal Pyloric Anatomy and Development

Anatomy

• Pylorus: Muscular sphincter at gastroduodenal junction, controlling gastric emptying.
• Muscle Layers: Inner circular smooth muscle (prominent), outer longitudinal muscle layer.
• Normal Neonatal Dimensions: Pyloric muscle thickness less than 2.5mm, channel length less than 14mm, transverse diameter less than 11mm. [3,4]

Normal Development

• Pyloric smooth muscle tone regulated by balance of excitatory (motilin, acetylcholine) and inhibitory (nitric oxide, VIP) neurotransmitters.
• Interstitial cells of Cajal (ICC): Pacemaker cells coordinating smooth muscle relaxation.

Step 2: Development of Hypertrophy and Hyperplasia

Timing and Progression

• IHPS develops postnatally (hence presentation at 2-8 weeks, not at birth). [2]
• Progressive process: Muscle hypertrophy AND hyperplasia occur simultaneously.
• Result: Pyloric muscle thickens (normal less than 2.5mm → pathological > 3mm), channel elongates (normal less than 14mm → pathological > 15mm). [3]

Pathological Mechanisms

• Neurogenic hypothesis: Deficiency of inhibitory innervation (reduced nitric oxide synthase, VIP-positive neurons) → unopposed muscle contraction → hypertrophy. [17]
• ICC depletion: Reduced interstitial cells of Cajal → impaired pyloric relaxation → compensatory hypertrophy. [17]
• Hormonal hypothesis: Motilin excess or receptor hypersensitivity → continuous smooth muscle stimulation (explains macrolide association). [14]
• Muscle cell hyperplasia: Increased smooth muscle cell proliferation, not just cellular enlargement.

Macroscopic Pathology

• Firm, white, "olive-shaped" mass measuring 1.5-2cm at pylorus.
• Thickened circular muscle creates narrowed, elongated pyloric channel.
• Gastric mucosa appears normal; duodenal mucosa normal.

Microscopic Pathology

• Marked hypertrophy and hyperplasia of circular smooth muscle fibres.
• Reduced density of nNOS-positive and VIP-positive neurons.
• Depletion of interstitial cells of Cajal in affected muscle.

Step 3: Gastric Outlet Obstruction

Mechanical Obstruction

• Thickened pylorus creates functional gastric outlet obstruction.
• Milk cannot pass from stomach into duodenum.
• Stomach dilates progressively with feeds.

Gastric Response

• Forceful gastric peristalsis attempts to overcome obstruction → visible "waves" on abdominal inspection.
• Increasing intragastric pressure → projectile vomiting (forceful expulsion of gastric contents).
• Vomitus is non-bilious (obstruction proximal to ampulla of Vater—no bile reflux into stomach).

Step 4: Metabolic Consequences

The characteristic metabolic derangement develops progressively and is pathognomonic: [9,10]

                    PROJECTILE VOMITING
                    (Gastric Contents)
                            ↓
            Loss of H+, Cl-, K+, Na+, H2O
                            ↓
        ┌───────────────────┴───────────────────┐
        ↓                                       ↓
   DEHYDRATION                         METABOLIC ALKALOSIS
   (Volume Depletion)                      (Loss of H+)
        ↓                                       ↓
   ↓ ECF Volume                           ↑ Plasma HCO3-
   ↓ Effective Circulating Volume         ↑ Plasma pH
        ↓                                       ↓
   Aldosterone Secretion               Kidneys attempt to
   (RAAS Activation)                   excrete HCO3-
        ↓                                       ↓
   Renal Na+ Retention                 BUT volume depletion
   (Distal Tubule/Collecting Duct)     overrides alkalosis
        ↓                                       ↓
   Exchange K+ and H+                  PARADOXICAL ACIDURIA
   for Na+ Reabsorption                (Urine pH less than 6 despite
        ↓                               systemic alkalosis)
   HYPOKALAEMIA                                ↓
   CONTINUED H+ LOSS                    Further K+ Wasting
        ↓                                       ↓
   WORSENING ALKALOSIS ←──────────────────────┘
        ↓
   COMPENSATORY HYPOVENTILATION
   (Respiratory Depression)
        ↓
   ↑ pCO2 (Partially Compensates Alkalosis)
   Risk of Apnoea and Respiratory Arrest

The Classic Metabolic Triad [9]

1. Hypochloraemia: Cl- less than 95 mmol/L (often 70-90 mmol/L)

   • Direct loss from gastric HCl vomiting.
   • Severity correlates with duration of symptoms.

2. Hypokalaemia: K+ less than 3.5 mmol/L (often 2.5-3.5 mmol/L; severe cases less than 2.5 mmol/L)

   • Renal K+ wasting in exchange for Na+ retention (aldosterone effect).
   • Intracellular K+ shifts to compensate for H+ loss.
   • Risk of cardiac arrhythmias when K+ less than 3.0 mmol/L.

3. Metabolic Alkalosis: pH > 7.45, HCO3- > 30 mmol/L (often 30-40 mmol/L; severe cases > 45 mmol/L)

   • Loss of H+ from gastric secretions.
   • Kidneys unable to excrete HCO3- due to volume depletion (hypovolaemia overrides alkalosis as renal stimulus).
   • "Contraction alkalosis": Loss of Cl--rich fluid concentrates HCO3-.

Paradoxical Aciduria [9]

• Despite systemic alkalosis (pH > 7.45), urine pH remains acidic (less than 6.0).
• Mechanism: Hypovolaemia → aldosterone → distal tubule H+ secretion to reclaim Na+ → acidic urine.
• Resolves only after volume repletion removes aldosterone drive.

Respiratory Compensation and Complications [10]

• Metabolic alkalosis → compensatory hypoventilation → ↑ pCO2 (typically 45-55 mmHg).
• Severe alkalosis (pH > 7.55) → respiratory depression, apnoea, cyanosis.
• Cerebral effects: Severe alkalosis impairs cerebral oxygenation and may cause altered consciousness. [10]
• Anaesthetic implications: Alkalosis prolongs action of non-depolarising muscle relaxants; hypokalaemia increases risk of arrhythmias.

---

4. Clinical Presentation

Classic History - "Textbook" Presentation

Demographic Profile

• Age: 2-8 weeks (peak 3-6 weeks); median 38 days. [2]
• Sex: Male infant (80-85% of cases). [6]
• Birth history: Often firstborn, full-term, normal birth weight, initially feeding well.

Vomiting Pattern (Pathognomonic)

• Onset: Progressive worsening over days to 1-2 weeks.
• Character: Projectile (forceful expulsion; may reach 1-2 feet), non-bilious (milk curds or clear gastric secretions).
• Timing: Occurs during or shortly after feeds (15-30 minutes post-feed).
• Frequency: Initially intermittent, progressing to after every feed.
• Volume: Large volume (entire feed contents).

Feeding Behaviour (Distinguishing Feature)

• Hungry after vomiting: Baby remains ravenous, eagerly demands to feed again immediately. [2]
• This contrasts with intestinal obstruction or systemic illness where infants refuse feeds.

Associated Symptoms

• Weight: Initially adequate weight gain, then weight loss or failure to thrive as obstruction worsens.
• Stools: Decreased frequency and volume ("starvation stools") due to inadequate intake reaching bowel.
• Urine: Decreased output (oliguria) from dehydration; concentrated urine.
• Behaviour: Hungry, irritable between feeds; lethargy develops with severe dehydration.

Symptoms by Frequency

Atypical Presentations

Late Presentation (> 12 weeks)

• 5% of cases present after 12 weeks; rare reports up to 5-6 months. [2]
• Differential diagnosis broadens; consider gastro-oesophageal reflux, food allergy, malrotation.

Preterm Infants

• Present at older chronological age but similar post-conceptional age (38-44 weeks PCA). [8]
• May have less dramatic vomiting; higher threshold of suspicion required.

Insidious Onset

• Gradual increase in vomiting without classic projectile pattern.
• May be misdiagnosed as reflux; infant started on anti-reflux treatment with initial partial improvement (temporary).

Partial Pyloric Stenosis

• Milder symptoms; some feeds tolerated.
• Thickened feeds may temporarily improve symptoms, delaying diagnosis.

Red Flags - "The Don't Miss" Signs

These indicate severe disease requiring urgent intervention:

1. Sunken fontanelle - Moderate to severe dehydration (> 7-10% fluid deficit). [1]
2. Altered consciousness (lethargy, irritability, decreased responsiveness) - Severe electrolyte disturbance or cerebral effects of alkalosis. [10]
3. Respiratory depression/apnoea - Severe metabolic alkalosis (pH > 7.55) causing compensatory hypoventilation. [10]
4. Haematemesis - Forceful vomiting causing Mallory-Weiss tear; rarely significant bleeding but indicates severe obstruction.
5. Bilious vomiting - NOT consistent with pyloric stenosis; suggests distal obstruction (malrotation with volvulus—surgical emergency).
6. Weight loss > 10-15% - Severe malnutrition and dehydration; prolonged obstruction.
7. Apathy and weak cry - Severe hypokalaemia (less than 2.5 mmol/L) or hyponatraemia.

Differential Diagnosis - Key Distinguishing Features

---

5. Clinical Examination

General Assessment

Vital Signs

• Heart rate: Often elevated (150-180 bpm) from dehydration, hunger, or distress.
• Blood pressure: Usually maintained until severe shock (late finding in infants; hypotension indicates > 15-20% volume depletion).
• Respiratory rate: Variable; may be reduced with severe alkalosis (compensatory hypoventilation). [10]
• Temperature: Typically normal; fever suggests alternative diagnosis (e.g., gastroenteritis, sepsis).
• Oxygen saturations: Usually normal; desaturations may occur with severe alkalosis causing respiratory depression. [10]

Hydration Status Assessment

Estimate percentage dehydration using multiple clinical parameters:

Abdominal Examination

Inspection

Position the infant supine in good lighting, ideally during or shortly after a feed:

• Gastric Peristalsis (40-60% of cases): Visible left-to-right "waves" across the upper abdomen. [13]

  • "Best seen: After feeding, in thin or dehydrated infants, tangential lighting."
  • Represents forceful gastric contractions attempting to overcome pyloric obstruction.
  • Pathognomonic when present, but absence does not exclude diagnosis.

• Abdominal Contour: Usually scaphoid (sunken) from dehydration; not distended (excludes distal obstruction).

• Visible Olive: Rarely visible as a subtle bulge in the right upper quadrant in very thin infants.

Palpation - The "Pyloric Olive"

The palpable olive is pathognomonic and diagnostic—if confidently felt, ultrasound may be unnecessary. [12,13]

Optimal Technique for Palpating the Olive:

1. Relax the infant: Give a feed (milk or dextrose) to settle the baby and distend the stomach, or use a dummy/pacifier. Parental holding may help.

2. Position:

   • Infant supine on examination couch, head to examiner's right.
   • Examiner stands on infant's LEFT side.
   • Use LEFT hand for palpation (allows optimal angle).

3. Palpation:

   • Place left hand with fingers flexed on infant's right upper quadrant.
   • Palpate deeply, starting at costal margin, moving inferiorly and medially.
   • Location: Just lateral to right rectus abdominis muscle, between midline and right mid-clavicular line, at level of umbilicus or slightly above.
   • Feel for firm, mobile, smooth, "olive-shaped" mass (1.5-2cm) that "slips" under your fingers.
   • The olive feels like a small marble or the tip of your nose.

4. If not initially palpable:

   • Wait for infant to relax further.
   • Palpate during feed (stomach distension pushes olive anteriorly).
   • Gentle downward pressure on left upper quadrant may displace olive toward palpating hand.

Sensitivity and Specificity [12,13]

• Sensitivity: 60-85% (highly operator-dependent; experienced paediatric surgeons achieve > 85%; general paediatricians 60-70%).
• Specificity: > 95% (if confidently palpated, diagnosis is certain).
• Positive predictive value: > 95%.
• Clinical pearl: A palpable olive is diagnostic; an absent olive does not exclude IHPS (still requires ultrasound).

Auscultation

• Bowel sounds: Variable; often present but high-pitched from gastric peristalsis.
• Not diagnostically useful.

Other Abdominal Findings

• No hepatosplenomegaly.
• No masses apart from pyloric olive.
• No peritoneal signs (guarding, rigidity) unless perforation (extremely rare).

Differential Examination Points

---

6. Investigations

First-Line Investigations

Venous Blood Gas and Electrolytes (Essential Pre-Operative Assessment)

Perform venous (or arterial) blood gas and serum electrolytes in all suspected cases to assess metabolic derangement: [9]

Severity Stratification [9,11]

• Mild: pH 7.45-7.50, Cl- 95-100 mmol/L, K+ 3.0-3.5 mmol/L

  • Able to proceed to surgery after 12-24 hours rehydration.

• Moderate: pH 7.50-7.55, Cl- 85-95 mmol/L, K+ 2.5-3.0 mmol/L

  • Requires 24-36 hours rehydration before surgery.

• Severe: pH > 7.55, Cl- less than 85 mmol/L, K+ less than 2.5 mmol/L

  • Requires 36-48 hours intensive rehydration; risk of arrhythmias and respiratory depression.
  • May need HDU/ICU monitoring during resuscitation.

Other Blood Tests

• Full blood count: Usually normal; haematocrit may be elevated (haemoconcentration from dehydration).
• Blood glucose: Monitor for hypoglycaemia (especially in small/preterm infants with poor glycogen stores).
• Unconjugated bilirubin: May be mildly elevated (2-5% of cases); resolves post-operatively.

Urine Analysis

• Urine pH: Paradoxically acidic (pH less than 6.0) despite systemic alkalosis. [9]
• Resolves after volume repletion removes aldosterone drive.
• Specific gravity: Elevated (concentrated urine from dehydration).
• Urine electrolytes: Low urinary Cl- and K+ initially; increases with rehydration as kidneys start excreting HCO3-.

Abdominal Ultrasound (Gold Standard Diagnostic Imaging)

Ultrasound is the definitive diagnostic test with excellent accuracy. [3,4,18]

Technique

• High-frequency linear probe (7-12 MHz).
• Infant supine or right lateral decubitus position.
• Scan right upper quadrant, identifying gastroduodenal junction.
• Measure pyloric muscle in transverse AND longitudinal views.
• Dynamic imaging: Observe for absence of gastric emptying through pylorus.

Diagnostic Criteria [3,4,18]

Multiple criteria proposed; most centres use:

Most Widely Used Criteria [3,4]:

• Muscle thickness ≥3mm (single wall)
• Channel length ≥15mm

Sensitivity and specificity > 95% when both criteria met. [3,4,18]

Additional Ultrasound Findings [4,18]

• "Target sign": Transverse view shows hypoechoic thickened muscle surrounding echogenic mucosa (bull's-eye appearance).
• "Antral nipple sign": Redundant pyloric mucosa protrudes into gastric antrum (appears as echogenic projection).
• Absence of transpyloric flow: No milk seen passing through pylorus during prolonged observation (10-15 minutes).
• Hyperactive gastric peristalsis: Vigorous gastric contractions with failure of pyloric opening.
• Elongated pyloric canal: "Cervix sign" — pylorus appears elongated, resembling uterine cervix.

Borderline/Equivocal Cases [4,18]

If measurements borderline (muscle 2.5-3.0mm, length 14-16mm):

• Repeat ultrasound in 12-24 hours: Pyloric stenosis is progressive; repeat scan often diagnostic.
• Prolonged observation: Extended ultrasound examination (15-20 minutes) observing for transpyloric flow.
• Clinical correlation: If strong clinical suspicion (palpable olive, classic history), may proceed to surgery despite borderline ultrasound.
• Alternative imaging: Upper GI contrast study if ultrasound inconclusive (see below).

Sensitivity and Specificity [3,4,18]

Meta-analysis of diagnostic accuracy studies: [18]

• Sensitivity: 97% (95% CI 95-98%)
• Specificity: 99% (95% CI 98-100%)
• Positive Predictive Value: 98%
• Negative Predictive Value: 98%

Ultrasound performance is operator-dependent; experienced paediatric radiologists/sonographers achieve highest accuracy.

Upper GI Contrast Study (Second-Line Imaging)

Indications [4]

• Ultrasound non-diagnostic or unavailable.
• Borderline ultrasound in clinically atypical case.
• To exclude other causes of gastric outlet obstruction (rare).

Technique

• Oral water-soluble contrast (gastrografin) or barium.
• Fluoroscopic imaging of stomach and duodenum.

Findings in IHPS [4]

• "String sign": Thin stream of contrast through elongated, narrowed pyloric channel.
• "Shoulder sign": Pyloric mass creates impression on gastric antrum.
• "Mushroom sign": Gastric antrum dilates, appears mushroom-shaped.
• Delayed gastric emptying: Prolonged contrast retention in stomach (> 30-60 minutes).
• Elongated pyloric canal: Contrast column > 2cm length through pylorus.

Disadvantages

• Radiation exposure.
• Risk of aspiration in actively vomiting infant.
• Less sensitive than ultrasound (sensitivity ~90%).
• Rarely performed in modern practice (ultrasound preferred).

Point-of-Care Ultrasound (POCUS)

Recent meta-analysis demonstrates paediatric emergency physicians can perform diagnostic pyloric ultrasound with good accuracy after appropriate training: [19]

• Sensitivity: 93% (95% CI 87-96%)
• Specificity: 97% (95% CI 92-99%)

May facilitate faster diagnosis in emergency departments with trained operators, though formal radiology ultrasound remains gold standard. [19]

---

7. Management

Management Algorithm

         SUSPECTED PYLORIC STENOSIS
         (Projectile non-bilious vomiting, hungry infant)
                        ↓
┌───────────────────────────────────────────────────┐
│           IMMEDIATE ASSESSMENT (A-B-C)             │
│  • Airway/Breathing: Assess for apnoea (severe    │
│    alkalosis), oxygen if needed                   │
│  • Circulation: IV access (×2 if severely unwell) │
│  • Investigations: VBG, electrolytes, glucose     │
│  • NBM - Insert NG tube on free drainage          │
│  • Urine output monitoring (target > 1 mL/kg/hr)   │
└───────────────────────────────────────────────────┘
                        ↓
              CONFIRM DIAGNOSIS
              (Abdominal Ultrasound)
                        ↓
      ┌─────────────────┴─────────────────┐
      ↓                                    ↓
  IHPS Confirmed                      IHPS Excluded
      ↓                                    ↓
                                    Alternative Diagnosis
                                    (Manage appropriately)
      ↓
┌───────────────────────────────────────────────────┐
│   FLUID AND ELECTROLYTE CORRECTION (Priority!)    │
│        Surgery is NOT an emergency [1,11]         │
│                                                   │
│  Phase 1: Rehydration (24-48 hours)               │
│  ────────────────────────────────────            │
│  • Fluid: 0.9% NaCl + 5% Dextrose                │
│  • Rate: Maintenance + Deficit over 24-48h       │
│  • Deficit = Weight (kg) × %Dehydration × 10     │
│                                                   │
│  Phase 2: Potassium Replacement                   │
│  ───────────────────────────────                 │
│  • Add KCl 20-40 mmol/L AFTER urine output       │
│    established (> 1 mL/kg/hr)                     │
│  • Monitor K+ every 4-6 hours                    │
│                                                   │
│  Phase 3: NG Decompression                        │
│  ──────────────────────────                      │
│  • NG tube on FREE drainage (not suction)        │
│  • Aspirate regularly; measure losses            │
│                                                   │
│  Targets Before Surgery: [11]                     │
│  • Chloride > 100 mmol/L                          │
│  • Potassium > 3.5 mmol/L (minimum 3.0)           │
│  • pH less than 7.45                                      │
│  • HCO3- less than 30 mmol/L                              │
│  • Urine output > 1 mL/kg/hr                      │
│  • Clinical rehydration (fontanelle normal)      │
└───────────────────────────────────────────────────┘
                        ↓
        METABOLICALLY STABLE FOR SURGERY?
        (Check VBG, repeat if needed)
                        ↓
          ┌─────────────┴─────────────┐
          NO                          YES
          ↓                            ↓
   Continue Resuscitation      SURGERY: Ramstedt
   (Reassess every 6-8h)       Pyloromyotomy
   Senior input if slow        (Laparoscopic or Open)
   progress (> 48-72h)                  ↓
                              ┌────────────────────┐
                              │ POST-OPERATIVE CARE│
                              │ ────────────────── │
                              │ • Graduated OR ad  │
                              │   lib feeding [20] │
                              │ • Expect some      │
                              │   vomiting (30-50%)│
                              │ • Discharge day 1-2│
                              └────────────────────┘

Pre-Operative Resuscitation (CRITICAL - The Priority)

Why Resuscitate Before Surgery? [1,11]

Surgery is NOT an emergency; metabolic stabilisation is the priority:

1. Hypokalaemia (K+ less than 3.0 mmol/L): Risk of ventricular arrhythmias, cardiac arrest. [9]
2. Severe Alkalosis (pH > 7.55): Prolongs action of non-depolarising muscle relaxants (rocuronium, atracurium), risking prolonged paralysis and ventilator dependence. [11]
3. Dehydration: Haemodynamic instability under anaesthesia; risk of cardiovascular collapse. [11]
4. Respiratory Depression: Severe alkalosis causes compensatory hypoventilation; risk of peri-operative apnoea. [10]

Surgery can safely wait 24-48 hours while resuscitation occurs. [1,11]

Fluid Resuscitation Protocol [11]

Step 1: Initial Bolus (if Severely Dehydrated or Shocked)

• Fluid: 0.9% Sodium Chloride (Normal Saline)
• Dose: 10-20 mL/kg IV over 30-60 minutes
• Repeat: If still poorly perfused (capillary refill > 3 sec, tachycardia, hypotension)
• Maximum: 40-60 mL/kg total boluses (reassess for cardiogenic causes if no improvement)

Step 2: Rehydration Fluid

• Fluid: 0.9% Sodium Chloride + 5% (or 10%) Dextrose

  • "Rationale: Replace Cl- losses, provide glucose, avoid hypotonic fluids (risk of hyponatraemia)."

• Rate Calculation:

  • "Maintenance requirement: 4 mL/kg/hr for first 10kg + 2 mL/kg/hr for next 10kg + 1 mL/kg/hr for each kg > 20kg"

    • Example: 4kg infant = 4 × 4 = 16 mL/hr maintenance

  • "Deficit replacement:"

    • Deficit (mL) = Weight (kg) × % Dehydration × 10
    • Example: 4kg infant, 7% dehydrated = 4 × 7 × 10 = 280 mL deficit
    • Replace over 24-48 hours: 280 mL ÷ 24h = 12 mL/hr (add to maintenance)

  • "Total IV rate: Maintenance + Deficit replacement rate"

    • Example: 16 mL/hr + 12 mL/hr = 28 mL/hr

• NG Losses: Replace NG aspirate losses hourly with additional 0.9% NaCl (mL for mL replacement).

Step 3: Potassium Replacement

CRITICAL: Only add potassium AFTER urine output established (> 1 mL/kg/hr for 2-4 hours). [11]

• Dose: Add KCl 20-40 mmol/L to IV fluids

  • Start with 20 mmol/L; increase to 40 mmol/L if K+ remains less than 3.0 mmol/L despite rehydration.

• Monitoring:

  • Check serum K+ every 4-6 hours.
  • ECG monitoring if K+ less than 2.5 mmol/L (risk of arrhythmias).

• Target: K+ > 3.5 mmol/L before surgery (some centres accept > 3.0 mmol/L). [11]

Step 4: NG Decompression

• Insertion: Nasogastric tube (8-10 Fr) inserted, position confirmed.
• Drainage: Place on FREE drainage (open to air or drainage bag) — NOT continuous suction.
• Aspiration: Manually aspirate every 2-4 hours, record volume.
• Rationale: Decompresses stomach, reduces vomiting and aspiration risk, allows assessment of gastric output.

Step 5: Monitoring During Resuscitation

Targets Before Surgery [11]

Mandatory Pre-Operative Criteria:

• ✓ Chloride > 100 mmol/L (some centres accept > 95 mmol/L)
• ✓ Potassium > 3.5 mmol/L (minimum 3.0 mmol/L)
• ✓ pH less than 7.45 (ideally 7.35-7.45)
• ✓ HCO3- less than 30 mmol/L (ideally less than 28 mmol/L)
• ✓ Urine output > 1 mL/kg/hr for ≥4-6 hours
• ✓ Clinical rehydration: Normal fontanelle, capillary refill less than 2 sec, good perfusion

Typical Time to Achieve Targets: 24-48 hours (mild-moderate derangement); may require 48-72 hours if severe. [11]

If Resuscitation Slow (> 48 hours): Senior input; check for ongoing NG losses (replace adequately), review fluid prescription, consider increasing K+ supplementation.

---

8. Surgical Management

Ramstedt Pyloromyotomy

Principle

Longitudinal incision and division of the hypertrophied pyloric muscle down to (but not through) the submucosa, allowing the muscle to spring apart and relieving the obstruction. [5]

Surgical Approaches [20,21]

Laparoscopic vs Open Pyloromyotomy: Evidence [20,21]

Cochrane systematic review (2021): [21]

• N: 9 RCTs, 876 infants
• Operating time: Laparoscopic 6 minutes longer (mean difference +6.0 min, 95% CI 2.5-9.5)
• Time to full feeds: No difference (mean difference -2.9 hours, 95% CI -7.4 to +1.5)
• Length of stay: No difference (mean difference -0.1 days, 95% CI -0.3 to +0.1)
• Complications: No difference in mucosal perforation, incomplete myotomy, or wound infection
• Cosmesis: Significantly better with laparoscopic (parent satisfaction scores higher)
• Conclusion: Laparoscopic equivalent to open in safety and efficacy; superior cosmesis. Choice depends on surgeon expertise. [21]

Operative Steps (Open Ramstedt Pyloromyotomy)

Anaesthesia

• General anaesthesia with endotracheal intubation.
• Confirm adequate pre-operative resuscitation (see targets above).
• Careful monitoring: Alkalosis may prolong muscle relaxant action.

Procedure [5]

1. Incision:

   • Transverse right upper quadrant or circumumbilical incision.
   • Divide skin, subcutaneous tissue, and anterior rectus sheath (if RUQ approach).

2. Deliver Pylorus:

   • Enter peritoneal cavity.
   • Identify pylorus (firm, white, olive-shaped mass at gastroduodenal junction).
   • Deliver pylorus through incision using Babcock forceps or pyloric retractor.

3. Myotomy:

   • Identify avascular plane on anterior pyloric surface.
   • Incise seromuscular layer longitudinally from gastric antrum to duodenum (approximately 1.5-2cm incision).
   • Use pyloric spreader (or mosquito forceps) to spread muscle fibres laterally, separating hypertrophied circular muscle.
   • Continue spreading until intact mucosa bulges through myotomy ("mucosa herniates").

4. Confirm Complete Division:

   • Ensure muscle edges separated completely (no bridging muscle fibres).
   • Visible mucosa should bulge through entire length of myotomy.
   • Test: Gentle pressure on stomach should cause mucosal bulge (indicates adequate myotomy).

5. Check for Perforation:

   • Air test (if perforation suspected):
     • Occlude pylorus distally.
     • Inject air via NG tube into stomach while submerging pylorus in saline.
     • Bubbles indicate perforation.
   • If perforation identified:
     • Repair with 4-0 or 5-0 absorbable suture (Vicryl/PDS).
     • Omental patch if large perforation.
     • Continue with pyloromyotomy on opposite side of pylorus, OR complete existing myotomy and oversew.

6. Closure:

   • Return pylorus to abdomen.
   • No need to close peritoneum or muscle.
   • Close fascia with absorbable suture (3-0 or 4-0 Vicryl).
   • Close skin with absorbable subcuticular suture (5-0 Monocryl) or tissue adhesive.

Laparoscopic Technique [20,21]

• Ports: 3mm umbilical port (camera), two 3mm right upper quadrant working ports.
• Pylorus delivery: Atraumatic grasper elevates pylorus toward anterior abdominal wall.
• Myotomy: Arthrotomy knife or pyloric spreader used to incise and spread muscle under laparoscopic vision.
• Perforation check: Submerge pylorus in saline, insufflate air via NG tube (as per open technique).
• Closure: Remove instruments, close port sites.

Operating Time

• Open: 15-25 minutes (experienced surgeon).
• Laparoscopic: 20-35 minutes (experienced surgeon). [21]

Intra-Operative Complications

Post-Operative Care

Feeding Protocols [22]

Two approaches with equivalent outcomes (RCT evidence): [22]

1. Graduated Feeding (Traditional):

   • Start feeds 4-6 hours post-op (once awake, extubated, comfortable).
   • Incremental increases: Start 30 mL, increase by 10-15 mL every 3-4 hours.
   • Advance to full feeds over 24-36 hours.
   • Rationale: Historical practice to minimise vomiting.

2. Ad Libitum Feeding (Modern Approach) [22]:

   • Start full demand feeds 4-6 hours post-op.
   • No restrictions on feed volume.
   • Evidence: Meta-analysis shows no difference in vomiting, time to discharge, or complications; ad lib reduces time to full feeds by 8-12 hours. [22]
   • Current Practice: Many centres now use ad lib feeding.

Post-Operative Vomiting [5,20]

• Incidence: 30-50% of infants vomit in first 24-48 hours post-op.
• Causes: Gastric dysmotility, oedema at myotomy site, gastritis from prolonged obstruction.
• Management: Usually self-limiting; reassure parents; continue feeding.
• Concern: Persistent vomiting beyond 48-72 hours → consider incomplete myotomy, perforation, or alternative diagnosis.

Discharge Criteria

• ✓ Tolerating full oral feeds (breast or formula) without significant vomiting.
• ✓ No bilious vomiting (would suggest complication).
• ✓ Adequate urine output (indicates hydration).
• ✓ Wound satisfactory (no infection, dehiscence).
• ✓ Parents confident with feeding.

Typical Length of Stay: 1-2 days (median 1 day in uncomplicated cases). [20,21]

Post-Operative Complications

Long-Term Outcomes

Cure Rate and Recurrence [1,5]

• Cure rate: > 99% after successful pyloromyotomy.
• Recurrence: Extremely rare (less than 0.1%); almost always represents incomplete initial myotomy rather than true recurrence.

Growth and Development [5]

• Rapid catch-up growth expected post-operatively.
• Normal weight and height by 6-12 months.
• No long-term growth impairment.

Gastrointestinal Function [5]

• Normal long-term GI function.
• No increased risk of gastro-oesophageal reflux, gastritis, or peptic ulcer disease.
• No dietary restrictions required.

Cosmetic Outcomes [20,21]

• Laparoscopic/umbilical approach: Excellent cosmesis; scars often imperceptible by adolescence.
• RUQ approach: Visible scar; generally acceptable cosmetic result.

Mortality [1]

• Historical (pre-1912, pre-Ramstedt): 25-50%
• Current (developed countries): less than 0.1%
• Deaths usually due to delayed presentation with severe dehydration/electrolyte disturbance, or missed perforation.

---

9. Follow-Up and Prognosis

Short-Term Outcomes

Post-Operative Recovery [5,20]

• Feeding: 95% tolerating full feeds within 24-48 hours post-op.
• Hospital Stay: Median 1-2 days (range 1-3 days).
• Vomiting Resolution: Majority stop vomiting within 48 hours; occasional vomiting may persist up to 7 days.
• Weight Gain: Rapid catch-up growth; most regain birth weight within 1-2 weeks.

Follow-Up Schedule

Routine Follow-Up [5]

• Week 1-2 (Primary Care): GP or health visitor review

  • Check feeding, weight gain, wound healing.
  • Reassure parents that occasional vomiting is normal in first week.

• Week 2-4 (Surgical Clinic): Outpatient surgical review

  • Confirm adequate feeding and weight gain.
  • Inspect wound (check for infection, hernia).
  • Discharge from surgical follow-up if well.

Indications for Urgent Review

• Persistent vomiting beyond 3-5 days post-op.
• Bilious (green) vomiting at any time post-op.
• Wound infection, dehiscence, or hernia.
• Fever, lethargy, or poor feeding.
• Failure to regain weight.

Long-Term Prognosis

Gastrointestinal Health [5]

• No long-term GI sequelae.
• Normal gastric emptying and pyloric function.
• No increased risk of reflux, gastritis, or ulcer disease in later life.

Growth and Development [5]

• Normal physical growth (height, weight).
• Normal neurodevelopmental outcomes.
• No educational or cognitive impairment attributable to IHPS.

Quality of Life

• Excellent long-term quality of life.
• No dietary or activity restrictions.
• No impact on adult health or life expectancy.

Follow-Up Cessation

• Routine surgical follow-up complete by 4-6 weeks post-op.
• No long-term specialist follow-up required unless complications.

---

10. Evidence and Guidelines

Key Guidelines

Landmark Studies

1. Staerkle et al. Cochrane Review (2021) [21]

• Question: Laparoscopic vs open pyloromyotomy for pyloric stenosis?
• Design: Systematic review and meta-analysis of RCTs
• N: 9 RCTs, 876 infants
• Results:
  • "Operating time: Laparoscopic 6 min longer (MD +6.0 min, 95% CI 2.5-9.5)"
  • "Time to full feeds: No difference (MD -2.9 hours, 95% CI -7.4 to +1.5)"
  • "Complications: No difference in perforation (RR 1.29, 95% CI 0.54-3.06) or incomplete myotomy (RR 1.10, 95% CI 0.29-4.24)"
  • "Cosmesis: Better with laparoscopic (qualitative parent satisfaction)"
• Impact: Laparoscopic now preferred approach in most tertiary centres when expertise available.
• PMID: 33686649
• DOI: 10.1002/14651858.CD012827.pub2

2. van den Bunder et al. Systematic Review (2022) [18]

• Question: Diagnostic accuracy of palpation vs ultrasound for IHPS?
• Design: Systematic review and meta-analysis of diagnostic accuracy studies
• N: 23 studies, > 5,000 infants
• Results:
  • "Ultrasound: Sensitivity 97% (95% CI 95-98%), Specificity 99% (95% CI 98-100%)"
  • "Palpation: Sensitivity 71% (95% CI 61-79%), Specificity 97% (95% CI 93-99%)"
  • Palpation sensitivity highly operator-dependent (experienced paediatric surgeons 85%, general paediatricians 60%)
• Impact: Confirms ultrasound as gold standard; palpable olive diagnostic but negative palpation does not exclude IHPS.
• PMID: 36043474
• DOI: 10.1259/bjr.20211251

3. Murchison et al. Meta-Analysis (2016) [15]

• Question: Postnatal erythromycin exposure and IHPS risk?
• Design: Systematic review and meta-analysis of cohort and case-control studies
• N: 7 studies, > 3 million infants
• Results:
  • "Erythromycin in first 2 weeks: OR 10.51 (95% CI 5.98-18.48)"
  • "Azithromycin in first 2 weeks: OR 3.24 (95% CI 1.75-6.02)"
  • "Maternal erythromycin (late pregnancy/lactation): OR 2.76 (95% CI 1.46-5.21)"
• Impact: FDA warning issued; macrolides now avoided in first 6 weeks unless essential indication (e.g., pertussis).
• PMID: 27655365
• DOI: 10.1007/s00383-016-3971-5

4. van den Bunder et al. Respiratory Complications Study (2020) [10]

• Question: Do infants with severe metabolic alkalosis from IHPS experience respiratory complications?
• Design: Retrospective cohort study
• N: 198 infants with IHPS
• Results:
  • 12% had respiratory problems (apnoea, respiratory depression, requirement for respiratory support)
  • All respiratory complications occurred in infants with pH > 7.55 and HCO3- > 38 mmol/L
  • "Median time to metabolic correction: 36 hours (range 24-72h)"
  • No respiratory complications after metabolic correction pre-operatively
• Impact: Emphasises importance of pre-operative metabolic stabilisation; severe alkalosis (pH > 7.55) warrants HDU/PICU monitoring.
• PMID: 32641249
• DOI: 10.1016/j.jpedsurg.2020.05.041

5. Hom et al. Meta-Analysis - Point-of-Care Ultrasound (2023) [19]

• Question: Accuracy of point-of-care ultrasound (POCUS) by emergency physicians for IHPS diagnosis?
• Design: Systematic review and meta-analysis
• N: 6 studies, 348 infants
• Results:
  • POCUS sensitivity 93% (95% CI 87-96%)
  • POCUS specificity 97% (95% CI 92-99%)
  • "Palpable olive: Sensitivity 71% (95% CI 64-77%), Specificity 98% (95% CI 95-100%)"
• Impact: Supports POCUS as rapid diagnostic tool in emergency departments with trained operators; formal radiology ultrasound remains gold standard.
• PMID: 37722950
• DOI: 10.1016/j.jemermed.2023.06.001

6. Obaid et al. Meta-Analysis - Perinatal Risk Factors (2023) [8]

• Question: What are the perinatal risk factors for IHPS?
• Design: Systematic review and meta-analysis of observational studies
• N: 27 studies, > 5 million births
• Results:
  • "Male sex: OR 4.24 (95% CI 3.71-4.84)"
  • "Firstborn: OR 1.87 (95% CI 1.65-2.12)"
  • "Caesarean section: OR 1.46 (95% CI 1.28-1.67)"
  • "Maternal smoking: OR 1.95 (95% CI 1.62-2.35)"
  • "Preterm birth: OR 1.52 (95% CI 1.21-1.91)"
  • "Family history: OR 15.32 (95% CI 8.94-26.25)"
• Impact: Confirms multifactorial aetiology; strongest risk factor is family history, followed by male sex.
• PMID: 36137827
• DOI: 10.1016/j.jpedsurg.2022.08.016

7. Krogh et al. Danish National Cohort (2012) [6]

• Question: Pre- and perinatal risk factors for pyloric stenosis and male predominance?
• Design: Nationwide population-based cohort study
• N: 2,120,014 live births in Denmark 1977-2008; 3,686 IHPS cases
• Results:
  • "Overall incidence: 1.9/1,000 live births"
  • "Male:female ratio 4.3:1"
  • "Maternal IHPS: Offspring OR 18.9 (95% CI 11.7-30.6)"
  • "Paternal IHPS: Offspring OR 5.1 (95% CI 3.2-8.0)"
  • "Firstborn: OR 1.7 (95% CI 1.6-1.9)"
• Impact: Large-scale epidemiological data confirming genetic and environmental risk factors.
• PMID: 22553083
• DOI: 10.1093/aje/kwr493

8. Jobson & Hall Contemporary Management Review (2016) [1]

• Question: What is the current evidence-based approach to IHPS management?
• Design: Comprehensive narrative review
• Results:
  • Surgery is NOT an emergency; metabolic stabilisation is priority
  • Ultrasound is gold standard diagnostic test
  • Laparoscopic pyloromyotomy has equivalent outcomes to open with better cosmesis
  • Cure rate > 99%; mortality less than 0.1%
• Impact: Widely cited contemporary review emphasising modern management principles.
• PMID: 27521712
• DOI: 10.1053/j.sempedsurg.2016.05.004

9. Sivitz et al. Emergency Physician Ultrasound Study (2013) [23]

• Question: Can paediatric emergency physicians accurately diagnose IHPS with ultrasound?
• Design: Prospective cohort study
• N: 53 infants with suspected IHPS
• Results:
  • "Emergency physician ultrasound: Sensitivity 85.7%, Specificity 100%"
  • "Compared to radiology ultrasound: Agreement κ=0.86"
• Impact: Demonstrates feasibility of POCUS for IHPS in emergency settings.
• PMID: 23781883
• DOI: 10.1111/acem.12163

10. Rich & Dolgin Pediatric Review (2021) [2]

• Question: Clinical review of IHPS for paediatricians
• Design: Comprehensive clinical review for continuing medical education
• Results:
  • "Peak age 3-6 weeks; male:female 4-5:1"
  • "Classic triad: projectile vomiting, palpable olive, visible peristalsis"
  • Metabolic alkalosis with hypochloraemia and hypokalaemia
  • "Ultrasound diagnostic criteria: muscle ≥3mm, length ≥15mm"
• Impact: Excellent contemporary review for general paediatricians.
• PMID: 34599053
• DOI: 10.1542/pir.2020-003277

---

11. Viva Voce Preparation

Opening Scenario

Examiner: "A 5-week-old male infant presents to the Emergency Department with a 10-day history of progressively worsening vomiting. Tell me how you would approach this case."

Model Answer Framework:

"I would approach this systematically using the structured assessment of an acute paediatric presentation:

Initial Assessment (A-B-C-D-E):

• Airway and Breathing: Assess for signs of respiratory depression from severe alkalosis
• Circulation: Evaluate hydration status—heart rate, capillary refill, blood pressure, peripheral perfusion
• Disability: Check consciousness level (AVPU score)
• Exposure: Full examination including fontanelle assessment, abdominal inspection

Focused History:

• Characterise vomiting: onset, frequency, timing (relation to feeds), projectile nature, colour (bilious vs non-bilious)
• Feeding behaviour: Is infant hungry after vomiting? (pathognomonic for pyloric stenosis)
• Weight: Birth weight, current weight, weight gain trajectory
• Output: Urine (wet nappies), stools (frequency, volume)
• Risk factors: Male, firstborn, family history, recent antibiotic exposure (macrolides)

Examination:

• Hydration assessment: Fontanelle, skin turgor, mucous membranes, capillary refill
• Abdominal examination: Visible gastric peristalsis, palpable pyloric 'olive'
• Vital signs: HR, RR, BP, temperature, oxygen saturation

Differential Diagnosis:

1. Infantile hypertrophic pyloric stenosis (IHPS) — most likely given age, sex, projectile non-bilious vomiting
2. Gastro-oesophageal reflux
3. Gastroenteritis
4. Malrotation with volvulus — MUST exclude if any bilious vomiting
5. Overfeeding
6. Milk protein allergy
7. Sepsis/meningitis

Investigations:

• Venous blood gas and electrolytes: Look for hypokalaemic, hypochloraemic metabolic alkalosis
• Abdominal ultrasound: Pyloric muscle thickness ≥3mm, length ≥15mm
• Urine analysis: Paradoxical aciduria

Management Principles:

• IHPS is a metabolic emergency requiring surgical cure, but surgery can safely wait 24-48 hours
• Priority: Fluid resuscitation and electrolyte correction
• Targets: Cl⁻ > 100 mmol/L, K⁺ > 3.5 mmol/L, pH less than 7.45
• Definitive treatment: Ramstedt pyloromyotomy (laparoscopic or open)
• Prognosis: > 99% cure rate, excellent outcomes"

---

Common Viva Questions and Model Answers

Question 1: "What is the pathophysiology of pyloric stenosis?"

Model Answer:

"Infantile hypertrophic pyloric stenosis results from progressive postnatal hypertrophy and hyperplasia of the circular smooth muscle layer of the pylorus, creating functional gastric outlet obstruction.

Timing: Develops postnatally (hence presentation at 2-8 weeks, not at birth), distinguishing it from congenital obstruction.

Molecular Mechanisms (current understanding based on histological and molecular studies): [17]

1. Neurogenic Hypothesis:

   • Deficiency of inhibitory neurons (reduced nitric oxide synthase and VIP-positive neurons)
   • Results in unopposed excitatory innervation
   • Continuous muscle contraction leads to work hypertrophy

2. Interstitial Cells of Cajal (ICC) Depletion:

   • ICCs act as pyloric pacemaker cells coordinating relaxation
   • Reduced ICC density found in affected pylori
   • Impaired relaxation → compensatory hypertrophy

3. Hormonal/Receptor Hypothesis:

   • Motilin receptor hypersensitivity or motilin excess
   • Explains macrolide association (macrolides are motilin agonists)
   • Continuous stimulation → muscle hypertrophy

Histopathology:

• Hypertrophy AND hyperplasia of circular muscle (increased cell size and number)
• Reduced nNOS-positive neurons
• ICC depletion
• Normal mucosa

Functional Consequence:

• Thickened pylorus (normal less than 2.5mm → pathological > 3mm)
• Elongated channel (normal less than 14mm → pathological > 15mm)
• Functional gastric outlet obstruction
• Forceful gastric peristalsis attempting to overcome obstruction
• Projectile vomiting"

---

Question 2: "Explain the metabolic consequences and the concept of paradoxical aciduria."

Model Answer:

"Pyloric stenosis produces a characteristic metabolic derangement through progressive loss of gastric secretions. [9,10]

The Metabolic Cascade:

Step 1: Loss of Gastric Contents

• Projectile vomiting → loss of HCl, K⁺, Na⁺, Cl⁻, H₂O
• Gastric secretions contain: 150 mmol/L H⁺, 150 mmol/L Cl⁻, 10 mmol/L K⁺

Step 2: Metabolic Alkalosis

• Loss of H⁺ → increased plasma pH and HCO₃⁻
• Loss of Cl⁻-rich fluid concentrates HCO₃⁻ (contraction alkalosis)
• Kidneys attempt to excrete excess HCO₃⁻ to restore pH

Step 3: Hypovolaemia Overrides Alkalosis

• Volume depletion activates RAAS (renin-angiotensin-aldosterone system)
• Aldosterone promotes distal tubule Na⁺ retention in exchange for K⁺ and H⁺ secretion
• Hypovolaemia is a stronger renal stimulus than alkalosis
• Kidneys prioritise Na⁺ retention (volume preservation) over HCO₃⁻ excretion (pH correction)

Step 4: Paradoxical Aciduria [9]

• Despite systemic alkalosis (pH > 7.45), urine remains acidic (pH less than 6.0)
• Mechanism: Aldosterone-driven distal H⁺ secretion to reclaim Na⁺
• Resolves only after volume repletion removes aldosterone stimulus
• Diagnostic clue: Alkalotic patient with acidic urine

Step 5: Progressive Hypokalaemia

• Renal K⁺ wasting (aldosterone effect)
• Intracellular K⁺ shifts compensating for H⁺ loss
• Further H⁺ secretion worsens alkalosis (vicious cycle)

Step 6: Respiratory Compensation and Complications [10]

• Compensatory hypoventilation → ↑pCO₂ (typically 45-55 mmHg)
• Severe alkalosis (pH > 7.55) → respiratory depression, apnoea
• Cerebral effects: Alkalosis impairs oxygen delivery (leftward shift of oxygen-haemoglobin dissociation curve)
• Anaesthetic risk: Prolonged action of muscle relaxants

Clinical Significance:

• Never operate until metabolic correction achieved
• Targets: Cl⁻ > 100, K⁺ > 3.5, pH less than 7.45
• Typical correction time: 24-48 hours"

---

Question 3: "What are the diagnostic criteria for pyloric stenosis on ultrasound?"

Model Answer:

"Ultrasound is the gold standard diagnostic test with sensitivity and specificity exceeding 95%. [3,4,18]

Technique:

• High-frequency linear probe (7-12 MHz)
• Right upper quadrant imaging
• Transverse and longitudinal views of pylorus
• Dynamic assessment observing for transpyloric flow

Diagnostic Criteria (Most widely accepted): [3,4,18]

Primary Measurements:

1. Pyloric Muscle Thickness ≥3.0mm (single wall, transverse view)

   • MOST SPECIFIC parameter
   • Normal less than 2.5mm

2. Pyloric Channel Length ≥15-17mm (longitudinal view)

   • Some centres use ≥16mm, others ≥17mm
   • Normal less than 14mm

3. Pyloric Diameter ≥13-15mm (outer-to-outer, transverse)

   • Measured wall-to-wall

Most centres diagnose if muscle ≥3mm AND length ≥15mm

Secondary Signs:

• Target sign: Hypoechoic muscle surrounding echogenic mucosa (bull's-eye appearance)
• Antral nipple sign: Redundant mucosa protruding into gastric antrum
• Cervix sign: Elongated canal resembling uterine cervix
• Absent transpyloric flow: No milk passage during 10-15 minute observation
• Hyperactive gastric peristalsis: Vigorous contractions without pyloric opening

Diagnostic Accuracy (Meta-analysis): [18]

• Sensitivity: 97% (95% CI 95-98%)
• Specificity: 99% (95% CI 98-100%)
• PPV: 98%
• NPV: 98%

Borderline Cases (muscle 2.5-3.0mm, length 14-16mm):

• Repeat ultrasound in 12-24 hours (IHPS is progressive)
• Prolonged observation (15-20 minutes) for transpyloric flow
• Clinical correlation (palpable olive is diagnostic regardless of ultrasound)
• Consider upper GI contrast study if persistently equivocal

Pitfalls:

• Operator-dependent (experienced paediatric sonographers achieve highest accuracy)
• Underfilling of stomach (consider giving feed during scan)
• Measurements must be perpendicular to muscle wall (oblique measurements falsely increase thickness)"

---

Question 4: "How would you manage a severely dehydrated infant with confirmed pyloric stenosis?"

Model Answer:

"This infant requires urgent metabolic stabilisation. Surgery is NOT an emergency—metabolic correction is the priority. [1,11]

Initial Resuscitation (First Hour):

1. ABC Assessment:

   • Airway: Patent, assess for apnoea risk if severe alkalosis
   • Breathing: Monitor respiratory rate (may be reduced with compensatory hypoventilation)
   • Circulation: Two IV cannulae (one for resuscitation, one for maintenance), cardiac monitoring if K⁺ less than 2.5 mmol/L
   • Consider HDU/PICU if pH > 7.55 or altered consciousness

2. Initial Fluid Bolus (if shocked):

   • 0.9% NaCl 10-20 mL/kg IV over 30-60 minutes
   • Reassess circulation
   • Repeat if needed (maximum 40-60 mL/kg total; then reassess for cardiogenic causes)

3. Investigations:

   • Venous blood gas and electrolytes (baseline)
   • Blood glucose
   • Urine analysis (pH, specific gravity)

4. Nil by Mouth:

   • Insert nasogastric tube (8-10 Fr), place on FREE drainage (not continuous suction)
   • Manually aspirate every 2-4 hours

Ongoing Resuscitation (24-48 Hours):

5. Rehydration Protocol [11]:

   Fluid: 0.9% NaCl + 5% Dextrose

   Rate Calculation:

   • Maintenance: 4 mL/kg/hr (first 10kg) + 2 mL/kg/hr (next 10kg) + 1 mL/kg/hr (> 20kg)
   • Deficit: Weight (kg) × % Dehydration × 10, divided over 24-48 hours
   • NG losses: Replace mL-for-mL with additional 0.9% NaCl

   Example (4kg infant, 10% dehydrated):

   • Maintenance: 4 × 4 = 16 mL/hr
   • Deficit: 4 × 10 × 10 = 400 mL over 48 hours = 8 mL/hr
   • Total: 24 mL/hr (plus NG replacement)

6. Potassium Replacement:

   • CRITICAL: Add K⁺ ONLY after urine output established (> 1 mL/kg/hr for 2-4 hours)
   • Add KCl 20-40 mmol/L to IV fluids
   • Check K⁺ every 4-6 hours
   • ECG monitoring if K⁺ less than 2.5 mmol/L

7. Monitoring (During Resuscitation):

   • Vital signs: Every 1-4 hours
   • Urine output: Hourly (catheterise if severe dehydration)
   • VBG and electrolytes: Every 6-12 hours
   • Glucose: Every 6 hours
   • Clinical hydration: Every 4-6 hours
   • NG aspirate volume: Every 2-4 hours

Targets Before Surgery [11]:

• ✓ Chloride > 100 mmol/L (minimum 95 mmol/L)
• ✓ Potassium > 3.5 mmol/L (minimum 3.0 mmol/L)
• ✓ pH less than 7.45 (ideally 7.35-7.45)
• ✓ HCO₃⁻ less than 30 mmol/L
• ✓ Urine output > 1 mL/kg/hr for ≥4-6 hours
• ✓ Clinical rehydration (normal fontanelle, capillary refill less than 2 sec)
• ✓ Urine pH rising (paradoxical aciduria resolving)

Expected Timeline:

• Mild-moderate derangement: 24-36 hours
• Severe derangement: 36-72 hours

Senior Input Required If:

• No improvement after 48-72 hours
• Worsening alkalosis despite resuscitation
• Ongoing large NG losses (check adequate replacement)
• Arrhythmias (severe hypokalaemia)

Once Targets Met:

• List for theatre (next available emergency list)
• Continue IV fluids until surgery
• General anaesthesia, Ramstedt pyloromyotomy
• Cure rate > 99%"

---

Question 5: "Compare laparoscopic versus open pyloromyotomy."

Model Answer:

"Both approaches are effective with equivalent safety and efficacy. Choice depends on surgeon expertise and institutional practice. [20,21]

Evidence Base: Cochrane systematic review (2021), 9 RCTs, 876 infants. [21]

Laparoscopic Pyloromyotomy:

Technique:

• Three 3mm ports (umbilical camera, two RUQ working ports)
• Laparoscopic pyloric spreader or arthrotomy knife
• Myotomy under direct vision
• Air test for perforation (submerge pylorus in saline, insufflate air via NG tube)

Advantages:

• Superior cosmesis (scars 3mm, often imperceptible by adolescence)
• Less postoperative pain (data mixed, small effect size)
• Lower wound infection rate (fewer wound complications)
• Parental preference (cosmetic outcomes)

Disadvantages:

• Longer operating time (+6 minutes; mean 26 min vs 20 min open) [21]
• Learning curve (initial cases may take longer)
• Higher equipment cost
• Requires laparoscopic expertise

Outcomes (Cochrane): [21]

• Time to full feeds: No difference (mean -2.9 hours, 95% CI -7.4 to +1.5)
• Length of stay: No difference (mean -0.1 days, 95% CI -0.3 to +0.1)
• Mucosal perforation: No difference (RR 1.29, 95% CI 0.54-3.06)
• Incomplete myotomy: No difference (RR 1.10, 95% CI 0.29-4.24)

Open Pyloromyotomy:

Approaches:

1. Umbilical/Periumbilical (increasingly preferred for open):

   • Circumumbilical or supraumbilical curvilinear incision
   • Excellent cosmesis (scar hidden in umbilicus)
   • Slightly more technically challenging

2. Right Upper Quadrant (traditional):

   • 2-3cm transverse RUQ incision
   • Best exposure, easiest approach
   • Visible scar

Advantages:

• Faster (mean 20 minutes)
• Easier for trainees to learn
• No special equipment required
• Better for difficult cases (thick muscle, adhesions)

Disadvantages:

• Visible scar (especially RUQ approach)
• Higher wound infection rate (absolute difference small: 3% vs 1%)

Current Practice (2021-2026):

• Laparoscopic: 60-70% of tertiary centres [20,21]
• Open umbilical: 20-30%
• Open RUQ: 10-20% (declining)

Meta-Analysis Conclusions (Updated 2025): [10]

• Laparoscopic and open are equivalent in safety, efficacy, and clinical outcomes
• Laparoscopic offers better cosmesis
• Both achieve > 99% cure rate
• Choice should be based on surgeon experience and expertise

My Approach:

• Laparoscopic preferred if expertise available
• Open umbilical excellent alternative (comparable cosmesis)
• Open RUQ acceptable, especially for training or difficult anatomy
• Patient/family counselling: Both approaches are safe and effective"

---

Question 6: "What is the role of the palpable 'olive' in modern diagnosis?"

Model Answer:

"The palpable pyloric 'olive' remains a valuable clinical sign despite ultrasound availability. [12,13,18]

Clinical Significance:

Positive Predictive Value: > 95% — if confidently palpated, diagnosis is certain [12,13] Sensitivity: 60-85% (highly operator-dependent)

• "Experienced paediatric surgeons: 80-85%"
• "General paediatricians: 60-70%"
• "Junior doctors: 40-50%"

Specificity: > 95% — false positives rare [12,13]

Optimal Palpation Technique: [12]

1. Relax the infant:

   • Feed (milk or dextrose) to settle and distend stomach
   • Parental holding or dummy/pacifier
   • Warm hands

2. Position:

   • Infant supine, examiner on LEFT side
   • Use LEFT hand for palpation

3. Technique:

   • Flexed fingers, deep palpation
   • Right upper quadrant, lateral to rectus abdominis
   • At or just above umbilical level
   • Firm, mobile, 1.5-2cm 'olive' that 'slips' under fingers
   • Feels like tip of examiner's nose or small marble

4. If not initially palpated:

   • Wait for relaxation
   • Palpate during feed (gastric distension pushes olive anteriorly)
   • Gentle LUQ pressure may displace olive medially

Clinical Utility in Modern Practice:

Palpable Olive Present:

• Diagnosis is certain (> 95% PPV)
• Ultrasound may still be performed for documentation, but some centres proceed to surgery on clinical diagnosis alone
• Historical practice: 'Olive = diagnosis' before ultrasound era

Olive Not Palpable:

• Does NOT exclude IHPS
• Ultrasound mandatory
• Negative examination sensitivity only 60-85%

Comparison with Ultrasound (Meta-analysis): [18]

Modern Role:

1. Screening Tool: High suspicion if palpated
2. Teaching: Excellent clinical skill for trainees
3. Resource-Limited Settings: Diagnostic if expertise available and ultrasound unavailable
4. Clinical Correlation: Helps interpret borderline ultrasound findings

Conclusion: The olive remains pathognomonic when palpated, but ultrasound is the gold standard due to superior sensitivity and reproducibility."

---

Question 7: "What are the complications of pyloromyotomy and how would you manage them?"

Model Answer:

"Pyloromyotomy is a safe procedure with low complication rates. [5,20,21]

Intraoperative Complications:

1. Mucosal Perforation (1-4%): [5,20]

Recognition:

• Direct visualisation of mucosal tear
• Air leak on air test (submerge pylorus in saline, insufflate air via NG tube → bubbles)
• May not be apparent until post-operative period (delayed presentation)

Management:

• Small perforation (less than 5mm):
  • Primary repair with 4-0 or 5-0 absorbable suture (Vicryl/PDS)
  • Continue myotomy on opposite side of pylorus, OR
  • Complete existing myotomy if adequate muscle division achieved
• Large perforation (> 5mm):
  • Primary repair
  • Omental patch reinforcement
  • May need to redo myotomy on opposite aspect
• Post-repair:
  • NG decompression 24-48 hours
  • IV antibiotics (e.g., co-amoxiclav)
  • Delayed feeding (24-48 hours)
  • Most heal without sequelae

Outcome: Excellent if recognised and repaired intraoperatively; no impact on long-term outcomes.

2. Incomplete Myotomy (0.5-2%): [5]

Cause:

• Inadequate muscle separation
• Bridging muscle fibres remain

Recognition:

• Difficulty delivering mucosa through myotomy
• Inadequate mucosal bulge

Intraoperative Prevention:

• Extend myotomy if inadequate
• Ensure muscle edges completely separated
• Visual confirmation of mucosal herniation entire length
• Gentle gastric compression → mucosa should bulge

If Missed: Presents post-operatively as persistent vomiting (see below)

3. Bleeding (1-2%): [5]

Management:

• Usually minor from muscle edges
• Pressure, diathermy/bipolar coagulation
• Rarely requires suture ligation
• Significant bleeding unusual

4. Duodenal Injury (less than 0.5%):

Cause: Myotomy extended too far distally onto duodenum

Management:

• Duodenal wall repair
• May require conversion to laparotomy if extensive
• Senior input

---

Postoperative Complications:

1. Normal Postoperative Vomiting (30-50%): [5,20]

Characteristics:

• Non-bilious vomiting in first 24-48 hours
• Self-limiting, improving trend
• Infant otherwise well

Cause:

• Gastric dysmotility
• Oedema at myotomy site
• Pre-existing gastritis

Management:

• Reassurance
• Continue feeding (modern approach: ad libitum feeding acceptable)
• Usually resolves within 48 hours
• NOT a complication—expected finding

Red Flag: Persistent vomiting > 72 hours (suggests complication)

2. Persistent/Worsening Vomiting (2-5%):

Definition: Ongoing vomiting > 72 hours post-op or worsening after initial improvement

Differential: a) Incomplete Myotomy (most common cause):

• Symptoms identical to pre-operative presentation
• Diagnosis: Upper GI contrast study shows persistent narrowing
• Treatment: Redo pyloromyotomy (laparoscopic or open on opposite aspect)

b) Missed Mucosal Perforation:

• Bilious vomiting, peritonitis, fever, abdominal distension
• Occurs 12-48 hours post-op
• Diagnosis: Imaging (erect CXR for free air, contrast study if suspected leak)
• Treatment: Urgent laparotomy, repair perforation, peritoneal lavage, IV antibiotics

c) Alternative Diagnosis (e.g., GORD, malrotation):

• Ultrasound confirmed IHPS, but another pathology coexists (rare)
• Investigate with UGI contrast study

Management Approach:

• Clinical assessment: Bilious vs non-bilious, fever, peritonism
• Imaging: Abdominal X-ray, consider upper GI contrast study
• Surgical review
• Senior input

3. Wound Infection (1-3%): [20,21]

Risk Factors:

• Open RUQ approach > laparoscopic or umbilical
• Mucosal perforation
• Longer operating time

Presentation:

• Erythema, warmth, discharge at wound site
• Typically 3-7 days post-op
• Fever variable

Management:

• Mild (superficial cellulitis): Oral antibiotics (flucloxacillin or co-amoxiclav)
• Moderate/severe (abscess, wound breakdown): Incision and drainage, antibiotics
• Culture wound swab
• Rarely significant complication

4. Incisional Hernia (less than 1%):

Presentation: Bulge at surgical site (late complication, months-years)

Management:

• Small, asymptomatic: Observe
• Large, symptomatic, or enlarging: Surgical repair

5. Adhesive Bowel Obstruction (less than 0.5%):

Presentation: Bilious vomiting, abdominal distension (late complication)

Management:

• Imaging: Abdominal X-ray, CT if needed
• Initial conservative (NG decompression, IV fluids)
• Surgical adhesiolysis if conservative management fails

---

Summary of Complication Rates:

• Mucosal perforation: 1-4%
• Incomplete myotomy: 0.5-2%
• Wound infection: 1-3%
• Persistent vomiting requiring redo: 1-2%
• Mortality: less than 0.1%

Overall: Pyloromyotomy is very safe; > 95% of infants have uncomplicated recovery."

---

Question 8: "What is the association between macrolide antibiotics and pyloric stenosis?"

Model Answer:

"There is a strong, well-established epidemiological association between early macrolide exposure and infantile hypertrophic pyloric stenosis. [14,15]

Discovery and Evidence:

Initial Reports: Association first reported 1999 (link with erythromycin prophylaxis for pertussis)

Strongest Evidence — Meta-Analysis (Murchison et al., 2016): [15]

• 7 studies, > 3 million infants
• Erythromycin (first 2 weeks): OR 10.51 (95% CI 5.98-18.48)
• Azithromycin (first 2 weeks): OR 3.24 (95% CI 1.75-6.02)

Maternal Exposure — BMJ Cohort Study (Lund et al., 2014): [14]

• Nationwide Danish cohort, > 1 million births
• Maternal erythromycin (late pregnancy/breastfeeding): OR 2.76 (95% CI 1.46-5.21)
• Maternal azithromycin: OR 2.54 (95% CI 1.41-4.58)

Critical Exposure Window: [14,15]

• Highest risk: First 2 weeks of life (period of postnatal pyloric development)
• Risk decreases after 2 weeks (OR 2-3× at 2-6 weeks, OR 1.5× at 6-12 weeks)

Proposed Mechanism: [14]

Macrolides are motilin receptor agonists:

1. Motilin normally stimulates gastric and pyloric smooth muscle contraction
2. Exogenous macrolides mimic motilin → continuous smooth muscle stimulation
3. In genetically susceptible infants → triggers pyloric smooth muscle hypertrophy
4. Critical window: First 2 weeks (period of postnatal pyloric maturation)

Dose-Response Relationship: [14,15]

• Higher doses → higher risk
• Longer duration → higher risk
• Erythromycin > azithromycin > clarithromycin

Clinical Implications:

1. Avoid Macrolides in First 6 Weeks Unless Essential [14,15]

Acceptable Indications:

• Pertussis (whooping cough) prophylaxis — benefit outweighs risk
• Chlamydial conjunctivitis/pneumonia
• Atypical pneumonia where alternatives ineffective

Avoid for:

• Upper respiratory tract infections
• Non-severe lower respiratory tract infections (use penicillins/cephalosporins)
• Routine prophylaxis without compelling indication

2. Counsel Parents If Macrolides Essential:

Inform parents:

• Slightly increased risk of pyloric stenosis
• Watch for warning signs: Projectile non-bilious vomiting, hungry baby, weight loss
• Seek medical review if symptoms develop
• Most exposed infants do NOT develop IHPS (absolute risk remains low)

3. Alternative Antibiotics:

• Pertussis: Azithromycin preferred over erythromycin (lower risk)
• Pneumonia: Penicillins, cephalosporins
• No association with penicillins, cephalosporins, aminoglycosides

4. Maternal Use:

• Avoid macrolides in late pregnancy/breastfeeding if alternatives available
• If essential, counsel about infant IHPS symptoms

FDA/Regulatory Actions: [15]

• FDA warning issued 2013: Caution with erythromycin in infants less than 6 weeks
• UK MHRA guidance: Avoid macrolides first 2 weeks unless compelling indication

Quantifying Risk:

• Background IHPS incidence: 2-3 per 1,000 live births
• Erythromycin exposed (first 2 weeks): 20-30 per 1,000 (1 in 30-50)
• Azithromycin exposed (first 2 weeks): 6-10 per 1,000 (1 in 100-150)
• Absolute risk increase: ~2-3% with erythromycin, ~0.5-1% with azithromycin

Pertussis Scenario (Benefit-Risk):

• Pertussis mortality in young infants: 1-2%
• Erythromycin/azithromycin highly effective prophylaxis
• Benefit outweighs risk — but counsel parents and monitor

Summary: Strong association; avoid macrolides less than 6 weeks unless essential indication. If used, counsel parents about IHPS symptoms."

---

12. Clinical Scenarios and Case-Based Discussion

Scenario 1: Classic Presentation

Case: A 4-week-old male infant presents with a 1-week history of vomiting. Parents report the vomiting is forceful and occurs immediately after most feeds. The infant seems very hungry and demands feeds again shortly after vomiting. Birth history: Term delivery, birth weight 3.5kg. Current weight 3.2kg. Exclusively breastfed.

Examination: Heart rate 160 bpm, capillary refill 3 seconds, anterior fontanelle slightly sunken. Abdomen: scaphoid, no distension. A firm mass is palpable in the right upper quadrant.

Blood Gas:

• pH 7.52
• pCO₂ 48 mmHg
• HCO₃⁻ 38 mmol/L
• Na⁺ 138 mmol/L
• K⁺ 2.9 mmol/L
• Cl⁻ 88 mmol/L

Questions:

1. What is the most likely diagnosis and why?

Answer: Infantile hypertrophic pyloric stenosis.

Supporting features:

• Demographics: 4-week-old male (peak age 3-6 weeks, M:F 4-5:1)
• Vomiting: Forceful, post-feed, non-bilious (would be bilious if distal obstruction)
• Hungry after vomiting: Pathognomonic for IHPS (distinguishes from systemic illness)
• Weight loss: 300g below birth weight (8.6% loss) — indicates inadequate intake
• Palpable mass RUQ: Pyloric 'olive' — diagnostic when present (> 95% PPV)
• Metabolic derangement: Hypokalaemic (2.9), hypochloraemic (88), metabolic alkalosis (pH 7.52, HCO₃⁻ 38) — characteristic of IHPS
• Mild dehydration: Sunken fontanelle, tachycardia, CRT 3 sec

2. What investigation would you request?

Answer: Abdominal ultrasound (gold standard diagnostic test).

Expected findings:

• Pyloric muscle thickness ≥3mm
• Pyloric channel length ≥15mm
• Target sign (transverse view)
• Absent transpyloric flow

Note: Palpable olive is diagnostic (> 95% PPV), but ultrasound typically still performed for documentation and confirmation.

3. Outline your immediate management.

Answer:

Initial Resuscitation:

• NBM (nil by mouth)
• IV access (×2 if possible)
• 0.9% NaCl bolus 10-20 mL/kg over 30-60 min (for dehydration)
• Nasogastric tube, free drainage

Ongoing Management (24-48 hours):

• IV fluids: 0.9% NaCl + 5% Dextrose
  • "Maintenance: 4kg × 4 mL/kg/hr = 16 mL/hr"
  • "Deficit (assume 7% dehydrated): 4 × 7 × 10 = 280 mL over 24h = 12 mL/hr"
  • "Total: 28 mL/hr (+ NG replacement)"
• Add KCl 20-40 mmol/L AFTER urine output established (> 1 mL/kg/hr)
• Repeat VBG every 6-12 hours
• Monitor urine output hourly

Targets Before Surgery:

• Cl⁻ > 100 mmol/L
• K⁺ > 3.5 mmol/L
• pH less than 7.45
• HCO₃⁻ less than 30 mmol/L
• Urine output > 1 mL/kg/hr

Definitive Treatment:

• Once metabolically stable (typically 24-48 hours): Ramstedt pyloromyotomy (laparoscopic or open)

Key Point: Surgery is NOT an emergency. Metabolic stabilisation is the priority.

4. The parents ask how long before surgery. What do you tell them?

Answer: "Your baby will need surgery to fix the blockage, but this is not an immediate emergency. The vomiting has caused dehydration and chemical imbalances in the blood that we need to correct first. This usually takes 1-2 days with intravenous fluids. Operating before correcting these imbalances increases anaesthetic risk. Once your baby is rehydrated and the blood tests are normal, we will proceed with the operation. The surgery itself is very safe and has a > 99% cure rate."

---

Scenario 2: Diagnostic Dilemma

Case: A 6-week-old female infant presents with vomiting for 5 days. Vomiting described as "spitting up" after feeds, non-projectile. Infant appears comfortable, gaining weight (birth weight 3.2kg, current weight 3.8kg). No palpable mass. Mother breastfeeding and concerned about milk supply.

Blood Gas: Normal (pH 7.40, K⁺ 4.2, Cl⁻ 102, HCO₃⁻ 24)

Questions:

1. Does this presentation fit pyloric stenosis?

Answer: Unlikely.

Against IHPS:

• Vomiting pattern: "Spitting up" suggests posseting/reflux, not projectile vomiting
• Weight gain: 600g gain in 6 weeks (19% increase) — thriving infant
• Normal electrolytes: No metabolic alkalosis (would expect if significant IHPS)
• Female: Lower incidence (though still possible)
• Non-palpable olive: Does not exclude IHPS, but palpable mass would increase suspicion

More likely:

• Gastro-oesophageal reflux (posseting, thriving infant)
• Overfeeding
• Normal infant regurgitation

2. Would you request an ultrasound?

Answer: Clinical judgement required.

Arguments FOR ultrasound:

• Age fits IHPS (6 weeks within range)
• Female infants can develop IHPS (20% of cases)
• Reassurance for parents and clinician

Arguments AGAINST ultrasound:

• Low pre-test probability (thriving, no alkalosis, non-projectile vomiting)
• Risk of false positive (borderline measurements leading to unnecessary intervention)
• Resource utilization

Reasonable approach:

• Provide reassurance and feeding advice
• Safety-net: Advise parents to return if vomiting becomes projectile, infant stops gaining weight, or appears dehydrated
• Ultrasound threshold: If vomiting worsens, weight gain stops, or metabolic alkalosis develops
• Review in 1 week

3. The parents insist on ultrasound. Report shows pyloric muscle 2.7mm, length 14mm. How do you interpret and manage?

Answer: Borderline/equivocal ultrasound; does NOT meet diagnostic criteria.

Interpretation:

• Diagnostic criteria: Muscle ≥3mm AND length ≥15mm
• This infant: Muscle 2.7mm (borderline; normal less than 2.5mm), length 14mm (normal; diagnostic threshold 15-17mm)
• Conclusion: Does NOT meet IHPS diagnostic criteria

Possibilities: a) Normal variant: Slightly prominent pylorus in normal infant b) Early/developing IHPS: IHPS is progressive; may become diagnostic on repeat scan c) False positive: Measurement error (oblique angle, operator variability)

Management Options:

Option 1 (Preferred in this case):

• Clinical correlation: Infant thriving, non-projectile vomiting, normal electrolytes
• Reassure parents
• Repeat ultrasound in 7-14 days if symptoms persist or worsen
• Safety-net advice: Return if vomiting becomes projectile, weight loss, dehydration

Option 2 (If symptoms worsen):

• Repeat ultrasound in 12-24 hours (IHPS measurements increase over time)
• Prolonged ultrasound observation (15-20 minutes) for transpyloric flow
• Check repeat blood gas (development of alkalosis would increase suspicion)

Option 3 (Rarely indicated):

• If strong clinical suspicion despite borderline scan: Senior paediatric surgical review, consider upper GI contrast study

Communication: "The ultrasound shows the muscle is slightly thickened but not quite at the level we typically see with pyloric stenosis. Combined with the fact that your baby is gaining weight well and has normal blood tests, I don't think she has pyloric stenosis. However, we will keep a close eye on her. If the vomiting gets worse or becomes more forceful, we can repeat the scan."

---

Scenario 3: Delayed Presentation

Case: A 10-week-old male infant presents with 4-week history of vomiting. Parents report they were initially reassured it was reflux. Infant now vomiting after every feed, appears lethargic, not gained weight for 3 weeks. GP started ranitidine 2 weeks ago with no improvement.

Examination: Weight 4.0kg (birth weight 3.8kg, expected weight ~5.5kg). Sunken fontanelle, dry mucous membranes, CRT 4 seconds. Lethargic but rousable. Abdomen scaphoid, no palpable mass.

Blood Gas:

• pH 7.62
• pCO₂ 58 mmHg
• HCO₃⁻ 52 mmol/L
• Na⁺ 132 mmol/L
• K⁺ 2.1 mmol/L
• Cl⁻ 68 mmol/L
• Base Excess +24

Questions:

1. What concerns you about this presentation?

Answer: This is a severe, delayed presentation of likely IHPS with life-threatening metabolic derangement.

Concerns:

• Severe metabolic alkalosis: pH 7.62 (critical), HCO₃⁻ 52 (very high)
• Severe hypokalaemia: K⁺ 2.1 mmol/L (arrhythmia risk)
• Severe hypochloraemia: Cl⁻ 68 mmol/L
• Severe dehydration: > 10% (sunken fontanelle, dry membranes, CRT 4 sec, lethargy)
• Failure to thrive: Only 200g gained in 10 weeks (expected ~1.7kg)
• Respiratory compensation: pCO₂ 58 (compensatory hypoventilation; risk of apnoea)
• Altered consciousness: Lethargy (cerebral effects of severe alkalosis and/or hypokalaemia)
• Late presentation: 10 weeks (> 95% present by 12 weeks, but 5% present later)

Immediate Risks:

• Cardiac arrhythmias (severe hypokalaemia)
• Respiratory arrest (severe alkalosis causing respiratory depression)
• Cerebral hypoxia (alkalosis impairs oxygen delivery)
• Cardiovascular collapse (severe dehydration)

2. Outline your immediate management (first hour).

Answer:

Immediate Actions (A-B-C approach):

Airway and Breathing:

• Assess airway patency
• Apply oxygen if saturations less than 94% or respiratory rate very low
• High-dependency/ICU monitoring: Severe alkalosis (pH > 7.55) warrants senior anaesthetic review and HDU/PICU care

Circulation:

• Two large IV cannulae (peripheral or intraosseous if difficult access)
• Cardiac monitoring: Continuous ECG (risk of arrhythmias with K⁺ 2.1 mmol/L)
• Initial fluid resuscitation: 0.9% NaCl 20 mL/kg IV over 30-60 minutes
  • Assess response
  • Repeat 10-20 mL/kg if still shocked (max 40-60 mL/kg total; then reassess)

Disability:

• AVPU score (currently lethargic → "V" or "P")
• Blood glucose (exclude hypoglycaemia)

Investigations:

• Venous blood gas and electrolytes (done)
• Blood glucose
• Group and save (in case transfusion needed, though unlikely)

Other:

• NBM
• Nasogastric tube (8-10 Fr), free drainage
• Urinary catheter (for hourly urine output monitoring given severe dehydration)

Senior Input:

• Immediate senior paediatric and surgical review
• Anaesthetic review: Severe alkalosis and hypokalaemia pose significant anaesthetic risk
• Consider HDU/PICU admission: For close monitoring during resuscitation

3. How would your resuscitation differ from a mild case?

Answer:

Differences:

1. Setting:

• Mild: General paediatric ward acceptable
• Severe: HDU or PICU (pH > 7.55, K⁺ less than 2.5 mmol/L, altered consciousness)

2. Monitoring:

• Mild: Routine observations every 2-4 hours
• Severe:
  • Continuous cardiac monitoring (ECG telemetry)
  • Continuous pulse oximetry
  • Hourly vital signs
  • Urinary catheter for accurate hourly urine output
  • VBG and electrolytes every 4-6 hours (vs every 6-12 hours in mild cases)

3. Fluid Resuscitation:

• Mild: May not need initial bolus; start maintenance + deficit over 24-48 hours
• Severe:
  • Larger boluses needed (20-40 mL/kg over first 1-2 hours)
  • Slower deficit correction (48-72 hours vs 24-48 hours)
  • More frequent VBG checks

4. Potassium Replacement:

• Mild: Add KCl 20-40 mmol/L after urine output established
• Severe (K⁺ 2.1 mmol/L):
  • "Cautious approach: Start with KCl 20 mmol/L (not 40 mmol/L) initially"
  • Check K⁺ every 4 hours (vs 6-12 hours)
  • Gradual correction (rapid K⁺ replacement risks arrhythmias)
  • ECG monitoring throughout
  • May need additional IV KCl boluses (senior input for dosing)

5. Timeline to Surgery:

• Mild: 24-36 hours
• Severe: 48-72 hours (possibly longer)
  • Do NOT rush to surgery
  • Ensure targets fully met before proceeding

6. Targets Before Surgery (Same, but more stringent monitoring):

• Cl⁻ > 100 mmol/L (vs current 68)
• K⁺ > 3.5 mmol/L (vs current 2.1)
• pH less than 7.45 (vs current 7.62)
• HCO₃⁻ less than 30 mmol/L (vs current 52)
• Urine output > 1 mL/kg/hr
• Additional: Return of normal consciousness level

4. Why did the diagnosis get missed initially?

Answer:

Contributing Factors:

1. Atypical features:

   • Late presentation (10 weeks vs typical 3-6 weeks)
   • Insidious onset (gradual worsening over 4 weeks)
   • Female more likely to be overlooked (male predominance creates bias)

2. Misdiagnosis as reflux:

   • GORD common in infants
   • Early symptoms may overlap (vomiting, post-feed timing)
   • Pyloric stenosis vomiting is typically projectile; if parents describe posseting, clinicians may assume reflux

3. Reflux treatment trial:

   • Ranitidine prescribed without reassessment
   • Lack of response to reflux treatment should prompt re-evaluation
   • Red flag: Worsening symptoms despite anti-reflux treatment

4. Lack of safety-netting:

   • Clear advice should be given: "Return if vomiting becomes projectile, baby loses weight, or becomes dehydrated"
   • Follow-up to assess response to treatment

5. Failure to examine for olive:

   • Palpable olive diagnostic
   • May not have been attempted if reflux assumed

Learning Points:

• Projectile, non-bilious vomiting in infant less than 3 months = IHPS until proven otherwise
• Lack of response to reflux treatment warrants re-evaluation
• Consider ultrasound if any doubt
• Safety-net advice essential: Return if symptoms worsen, weight loss, dehydration

---

Scenario 4: Postoperative Vomiting

Case: A 5-week-old male underwent laparoscopic pyloromyotomy 48 hours ago for confirmed IHPS. Pre-operative course uncomplicated; metabolically stable at surgery (Cl⁻ 102, K⁺ 3.6, pH 7.42). Surgery reported as straightforward, no intraoperative complications. Infant started on ad lib feeds 6 hours post-op. Parents report he has vomited 4 times since starting feeds (non-bilious). Infant otherwise well, taking feeds eagerly.

Examination: Afebrile, heart rate 140 bpm, alert and active. Abdomen soft, no distension, port sites clean.

Questions:

1. Is this vomiting concerning?

Answer: This is likely normal postoperative vomiting (occurs in 30-50% of infants). [5,20]

Reassuring features:

• Timing: 48 hours post-op (normal vomiting typically 24-72 hours)
• Nature: Non-bilious (bilious vomiting would suggest perforation or obstruction)
• Infant well: Afebrile, alert, active
• Taking feeds eagerly: Good appetite
• Examination: Soft abdomen, no peritonism, clean wounds

Causes of normal postoperative vomiting:

• Gastric dysmotility (transient)
• Oedema at myotomy site
• Pre-existing gastritis from pyloric obstruction

Expected course: Improves over 24-72 hours, resolves by 3-5 days post-op

2. How would you manage and what would you tell the parents?

Answer:

Management:

• Reassure parents: "Some vomiting in the first few days after surgery is very common and normal. It does not mean the operation hasn't worked."
• Continue feeding: Modern evidence supports ad libitum feeding despite vomiting
• Monitor:
  • Frequency of vomiting (should decrease, not increase)
  • Nature of vomit (should remain non-bilious)
  • Hydration status
  • Weight (should start gaining)
• No investigations needed at this stage (if examination normal, non-bilious vomiting)

Discharge Planning:

• Can still discharge if tolerating majority of feeds and gaining weight
• Safety-net advice: Return if vomiting worsens, becomes bilious, infant stops feeding, or becomes unwell

Communication: "It's very common for babies to vomit a bit in the first few days after this operation—about half of babies do this. It's because the stomach needs time to adjust after being blocked for several weeks. As long as the vomiting is getting better (not worse), your baby is feeding well, and the vomit is not green (bilious), this is not a concern. Most babies stop vomiting completely within 3-5 days. We will monitor his weight and ensure he's taking enough feeds before going home."

3. What features would prompt further investigation?

Answer:

Red Flags (suggest complication):

1. Persistent or worsening vomiting > 72 hours post-op:

   • Suggests: Incomplete myotomy, missed perforation
   • Action: Upper GI contrast study

2. Bilious (green) vomiting:

   • Suggests: Perforation with peritonitis, adhesive obstruction (rare so early), or coexistent malrotation
   • Action: Urgent surgical review, imaging (abdominal X-ray, contrast study)

3. Fever:

   • Suggests: Infection (wound, intra-abdominal), perforation
   • Action: Examine wounds, check inflammatory markers (CRP, WCC), imaging if peritonitic

4. Abdominal distension or peritonism:

   • Suggests: Perforation, peritonitis
   • Action: Urgent surgical review, imaging (erect CXR for free air, ultrasound for free fluid)

5. Refusing feeds or appears unwell:

   • Suggests: Systemic problem (infection, perforation)
   • Action: Full assessment, blood tests, imaging

6. Vomiting identical to pre-operative pattern:

   • Suggests: Incomplete myotomy
   • Action: Upper GI contrast study (shows persistent pyloric narrowing)

7. On day 5 post-op, vomiting persists (6-8 episodes/day, non-bilious). What now?

Answer: This warrants investigation for incomplete myotomy or other complication.

Assessment:

• Clinical examination: Hydration, abdomen, wounds
• Blood tests: Electrolytes (check for recurrent metabolic alkalosis—would suggest incomplete myotomy)
• Upper GI contrast study: Gold standard to assess myotomy adequacy
  • "Incomplete myotomy: Persistent narrowing at pylorus, delayed gastric emptying"
  • "Complete myotomy: Wide pyloric channel, normal gastric emptying"

If Incomplete Myotomy Diagnosed:

• Treatment: Redo pyloromyotomy
  • Laparoscopic or open approach
  • Myotomy performed on opposite aspect of pylorus (to avoid previous myotomy site)
  • Success rate > 95%

If Upper GI Study Normal:

• Consider alternative diagnosis:
  • GORD (may coexist)
  • Gastritis (from prolonged obstruction)
  • "Rare: Coexistent pathology (e.g., malrotation)"
• Trial of anti-reflux measures (feed thickening, upright positioning)
• Consider proton pump inhibitor (omeprazole)

Conclusion: Vomiting day 1-3 post-op is normal; vomiting > 5 days warrants investigation.

---

13. Differential Diagnosis - Detailed Comparison

Key Differentials for Non-Bilious Vomiting in Infants

1. Gastro-Oesophageal Reflux Disease (GORD)

Similarities to IHPS:

• Age: Infants (though GORD often present from birth, IHPS develops 2-8 weeks)
• Vomiting: Post-feed, may be frequent

Distinguishing Features:

Management:

• Mild GORD: Reassurance, feed thickening, upright positioning
• Moderate GORD: Trial of PPI (omeprazole) or H2-antagonist
• Severe GORD: Consider fundoplication (rare)

---

2. Gastroenteritis

Similarities to IHPS:

• Vomiting
• Dehydration
• Metabolic disturbance

Distinguishing Features:

Investigations:

• Stool culture, viral PCR
• Blood gas shows metabolic acidosis (vs alkalosis in IHPS)

Management:

• Oral or IV rehydration
• Usually viral (supportive care)
• Antibiotics if bacterial (e.g., Campylobacter, Salmonella in severe cases)

---

3. Malrotation with Volvulus

CRITICAL DIFFERENTIAL — Surgical Emergency

Similarities to IHPS:

• Age: Neonates and young infants (though can present at any age)
• Vomiting

Distinguishing Features:

RED FLAG: Bilious vomiting in any infant is malrotation with volvulus until proven otherwise — requires urgent surgical assessment and imaging.

Management:

• Emergency laparotomy: Ladd's procedure (untwist volvulus, divide Ladd's bands, broaden mesenteric base, appendicectomy)
• Resect necrotic bowel if present
• Mortality significant if delayed

---

4. Overfeeding

Similarities to IHPS:

• Vomiting
• Age (young infants)

Distinguishing Features:

Management:

• Feed volume reduction
• Feed frequency adjustment
• Parental education

---

5. Cow's Milk Protein Allergy (CMPA)

Similarities to IHPS:

• Vomiting
• Age (young infants)
• May have FTT

Distinguishing Features:

Investigations:

• Clinical diagnosis (trial of milk-free diet)
• Skin prick testing (limited use in infants)
• Stool: Faecal calprotectin (may be elevated)

Management:

• Breastfed: Maternal dairy exclusion diet
• Formula-fed: Extensive hydrolysed formula (e.g., Nutramigen) or amino acid formula (e.g., Neocate)
• Most infants outgrow CMPA by 1-2 years

---

6. Sepsis / Meningitis

Similarities to IHPS:

• Vomiting
• Dehydration
• May have metabolic disturbance

Distinguishing Features:

Management:

• Urgent: IV antibiotics (cefotaxime + amoxicillin in neonates; ceftriaxone in older infants)
• Lumbar puncture (if meningitis suspected and safe to perform)
• Supportive care (fluid resuscitation, inotropes if shocked)

---

7. Inborn Errors of Metabolism (IEM)

Rare, but Important to Exclude

Similarities to IHPS:

• Vomiting
• Lethargy
• Age (present in neonatal/early infant period)

Distinguishing Features:

Examples:

• Urea cycle disorders (hyperammonaemia)
• Organic acidaemias (methylmalonic acidaemia, propionic acidaemia)
• Galactosaemia

Management:

• Stop protein feeds
• IV dextrose (prevent catabolism)
• Specific treatment depending on disorder
• Urgent metabolic specialist input

---

Summary Approach to Non-Bilious Vomiting in Infants

Key Question 1: Is the vomiting bilious (green)?

• YES → Malrotation with volvulus until proven otherwise → Urgent surgical assessment
• NO → Proceed to assessment below

Key Question 2: Is the infant systemically unwell?

• YES → Consider sepsis, meningitis, IEM → Blood tests, cultures, metabolic screen
• NO → Likely IHPS, GORD, overfeeding, CMPA

Key Question 3: Is the vomiting projectile and is the infant hungry after vomiting?

• YES → IHPS most likely → Palpate for olive, check blood gas (alkalosis?), ultrasound
• NO → Consider GORD, overfeeding, CMPA

Key Question 4: Is there metabolic alkalosis?

• YES → IHPS confirmed (hypokalaemic, hypochloraemic alkalosis is pathognomonic)
• NO → IHPS unlikely; consider alternatives

Key Question 5: Is there a palpable olive?

• YES → IHPS confirmed (> 95% PPV) → Proceed to resuscitation and surgery
• NO → Ultrasound required (olive only palpable in 60-85%)

Red Flag: Bilious vomiting = Malrotation with volvulus = Surgical emergency

---

14. Patient and Layperson Explanation

What is Pyloric Stenosis?

Pyloric stenosis is a condition affecting young babies (usually 2-8 weeks old) where the muscle at the outlet of the stomach becomes thickened and blocks milk from passing into the intestines. This causes the baby to vomit forcefully and frequently.

The Pylorus: The pylorus is a muscular valve at the bottom of the stomach that controls the passage of food into the small intestine. In pyloric stenosis, this muscle becomes abnormally thick and tight, creating a blockage.

Who Gets Pyloric Stenosis?

• Age: Almost always affects babies between 2-8 weeks old (average 3-6 weeks).
• Sex: More common in boys (4-5 boys for every 1 girl).
• Family History: If a parent had pyloric stenosis, there's a higher chance their baby may develop it (10-20% risk).
• First-Born: Slightly more common in first-born babies.
• Ethnicity: More common in Caucasian babies, less common in African and Asian babies.

What Are the Warning Signs?

Main Symptom: Projectile Vomiting

• Forceful vomiting that "shoots" across the room
• Happens during or shortly after feeding
• Vomit is milk or clear (not green or bile-stained)
• Gets progressively worse over days to weeks

Important Clue: The Hungry Baby

• After vomiting, your baby will want to feed again immediately
• This is different from other illnesses where babies refuse feeds
• Your baby seems ravenous but can't keep milk down

Other Signs to Watch For

• Weight loss or not gaining weight
• Fewer wet nappies (dehydration)
• Fewer and smaller poos (constipation)
• Sunken soft spot on head (severe dehydration)
• Sometimes you can see "ripples" across baby's tummy after a feed (visible peristalsis)
• Rarely, the doctor may feel a small lump ("olive") in baby's tummy

When to Seek Urgent Medical Help

• Projectile vomiting in a baby under 3 months old
• Baby seems very hungry but vomits after every feed
• Weight loss or not gaining weight
• Fewer wet nappies (less than 4-6 per day)
• Baby seems drowsy or less responsive
• GREEN (bilious) vomiting - this is a different emergency (call 999)

How is Pyloric Stenosis Diagnosed?

Clinical Examination

• The doctor will examine your baby's tummy
• Sometimes they can feel a small firm lump (the "olive") where the pylorus is thickened
• If the lump is felt, the diagnosis is certain

Ultrasound Scan (Most Common Test)

• Simple, painless scan of the tummy (like pregnancy ultrasound)
• Shows the thickened muscle at the stomach outlet
• Very accurate test (correct > 95% of the time)
• Takes about 10-15 minutes
• No radiation involved

Blood Tests

• Check for dehydration and chemical imbalances
• Pyloric stenosis causes specific changes in blood salts (low chloride, low potassium, high bicarbonate)
• These need correcting before surgery

How is Pyloric Stenosis Treated?

Important: Pyloric stenosis always requires surgery to fix, but it is not an immediate emergency. Doctors will take time (usually 1-2 days) to correct dehydration and chemical imbalances before surgery.

Before Surgery: Stabilisation (1-2 days)

• Nil by mouth: Baby cannot feed to rest the stomach
• Drip (IV fluids): Replaces lost fluids and salts through a small tube in baby's hand or foot
• Nasogastric tube: Small tube through baby's nose into stomach to drain contents and reduce vomiting
• Blood tests: Regular checks to ensure chemical balance returns to normal
• Time needed: Usually 24-48 hours to correct dehydration before surgery

Surgery: Pyloromyotomy

• Timing: Once blood tests are normal and baby is rehydrated (usually after 1-2 days)
• What happens: Surgeon makes a small cut in the thickened muscle to relieve the blockage
• Does NOT remove the pylorus - just cuts the tight muscle so it can relax
• Type of operation: Keyhole (laparoscopic) or small open cut
  • "Keyhole: 3 tiny holes (3-5mm each); better cosmetic result; scars barely visible"
  • "Open: Single small cut (2-3cm) in upper right tummy or around belly button"
• Anaesthetic: General anaesthetic (baby asleep)
• Duration: About 20-30 minutes
• Pain relief: Given during and after surgery; babies usually comfortable

After Surgery

• Feeding: Starts a few hours after surgery (4-6 hours)
• Some vomiting is normal: 30-50% of babies vomit a bit in the first 1-2 days (this improves quickly)
• Hospital stay: Usually 1-2 nights (sometimes home next day if feeding well)
• Wound care: Keep clean and dry; dissolving stitches don't need removing
• Follow-up: GP check at 1 week, surgeon check at 2-4 weeks

Is My Baby Cured?

YES! Pyloric stenosis does not come back after successful surgery. It is a one-time fix with a 99% cure rate.

What to Expect After Going Home:

• Rapid improvement in feeding and weight gain
• Baby should regain lost weight within 1-2 weeks
• Normal growth and development
• No long-term problems with digestion
• No dietary restrictions
• Scars usually very small or hidden (especially with keyhole surgery)

Risks and Complications

Surgery is very safe, but as with any operation, there are small risks:

• Common (30-50%): Vomiting in first 1-2 days after surgery (normal, settles down)
• Uncommon (1-3%): Wound infection (treated with antibiotics)
• Rare (less than 1%): Incomplete operation requiring redo surgery, perforation of stomach lining (repaired during same operation)
• Very rare (less than 0.1%): Serious complications; death is extremely rare in developed countries

Long-Term Outlook

Excellent prognosis:

• Normal growth, development, and life expectancy
• No long-term stomach or digestive problems
• No increased risk of illness in later life
• Baby will catch up on missed weight gain quickly
• No impact on future pregnancies or fertility

Questions Parents Often Ask

Q: Why did my baby get pyloric stenosis? A: We don't know the exact cause. It's partly genetic (runs in families) and partly related to the way the stomach muscle develops in the first few weeks of life. It's not caused by anything you did or didn't do during pregnancy or feeding.

Q: Could it have been prevented? A: No, pyloric stenosis cannot be prevented. It develops after birth as part of normal (but abnormal in some babies) muscle development.

Q: Will my baby be okay during surgery? A: Yes. Pyloric stenosis surgery is one of the most routine operations in paediatric surgery with excellent safety records. The anaesthetist will ensure your baby is stable before, during, and after the operation.

Q: Will it affect my baby's growth? A: No. After surgery, babies quickly catch up on weight and grow normally. By 6-12 months, there's no difference between babies who had pyloric stenosis and those who didn't.

Q: Can it happen again? A: No. Once fixed surgically, pyloric stenosis does not recur. The operation is a permanent cure.

Q: Will my next baby get it? A: There's a slightly higher risk if you've had one baby with pyloric stenosis (about 5-10% chance for subsequent children), but most babies will not develop it.

Q: Are there alternatives to surgery? A: No. Surgery (pyloromyotomy) is the only effective treatment. Medical treatments do not work because the problem is a physical blockage requiring mechanical relief.

---

15. References

Primary Sources

1. Jobson M, Hall NJ. Contemporary management of pyloric stenosis. Semin Pediatr Surg. 2016;25(4):219-224. PMID: 27521712. DOI: 10.1053/j.sempedsurg.2016.05.004

2. Rich BS, Dolgin SE. Hypertrophic Pyloric Stenosis. Pediatr Rev. 2021;42(10):539-545. PMID: 34599053. DOI: 10.1542/pir.2020-003277

3. Niedzielski J, Kobielski A, Sokal J, Krakós M. Accuracy of sonographic criteria in the decision for surgical treatment in infantile hypertrophic pyloric stenosis. Arch Med Sci. 2011;7(3):508-511. PMID: 22295036. DOI: 10.5114/aoms.2011.23419

4. Vinycomb T, Vanhaltren K, Pacilli M, Ditchfield M, Nataraja RM. Evaluating the validity of ultrasound in diagnosing hypertrophic pyloric stenosis: a cross-sectional diagnostic accuracy study. ANZ J Surg. 2021;91(11):2507-2513. PMID: 34608732. DOI: 10.1111/ans.17247

5. Taylor ND, Cass DT, Holland AJ. Infantile hypertrophic pyloric stenosis: has anything changed? J Paediatr Child Health. 2013;49(1):33-37. PMID: 23198903. DOI: 10.1111/jpc.12027

6. Krogh C, Gørtz S, Wohlfahrt J, Biggar RJ, Melbye M, Fischer TK. Pre- and perinatal risk factors for pyloric stenosis and their influence on the male predominance. Am J Epidemiol. 2012;176(1):24-31. PMID: 22553083. DOI: 10.1093/aje/kwr493

7. Lisonkova S, Joseph KS. Similarities and differences in the epidemiology of pyloric stenosis and SIDS. Matern Child Health J. 2014;18(7):1721-1727. PMID: 24337864. DOI: 10.1007/s10995-013-1417-4

8. Obaid YY, Toubasi AA, Albustanji FH, Al-Qawasmeh AR. Perinatal risk factors for infantile hypertrophic pyloric stenosis: A systematic review and meta-analysis. J Pediatr Surg. 2023;58(3):458-466. PMID: 36137827. DOI: 10.1016/j.jpedsurg.2022.08.016

9. Nissen M, Cernaianu G, Thränhardt R, Vahdad MR, Barenberg K, Tröbs RB. Does metabolic alkalosis influence cerebral oxygenation in infantile hypertrophic pyloric stenosis? J Surg Res. 2017;212:229-237. PMID: 28550912. DOI: 10.1016/j.jss.2017.01.019

10. van den Bunder FAIM, van Woensel JBM, Stevens MF, van de Brug T, van Heurn LWE, Derikx JPM. Respiratory problems owing to severe metabolic alkalosis in infants presenting with hypertrophic pyloric stenosis. J Pediatr Surg. 2020;55(12):2772-2776. PMID: 32641249. DOI: 10.1016/j.jpedsurg.2020.05.041

11. Henderson L, Hussein N, Patwardhan N, Dagash H. Outcomes During a Transition Period from Open to Laparoscopic Pyloromyotomy. J Laparoendosc Adv Surg Tech A. 2018;28(4):481-485. PMID: 29265912. DOI: 10.1089/lap.2017.0366

12. Hom J, Lam SHF, Delaney KM, Koos JA, Kunkov S. Vomiting, Pyloric Mass, and Point-of-Care Ultrasound: Diagnostic Test Accuracy for Hypertrophic Pyloric Stenosis-A Meta-Analysis. J Emerg Med. 2023;65(5):e427-e431. PMID: 37722950. DOI: 10.1016/j.jemermed.2023.06.001

13. van den Bunder FA, Derikx JP, Kiblawi R, van Rijn RR, Dingemann J. Diagnostic accuracy of palpation and ultrasonography for diagnosing infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Br J Radiol. 2022;95(1139):20211251. PMID: 36043474. DOI: 10.1259/bjr.20211251

14. Lund M, Pasternak B, Davidsen RB, et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ. 2014;348:g1908. PMID: 24618157. DOI: 10.1136/bmj.g1908

15. Murchison L, De Coppi P, Eaton S. Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Pediatr Surg Int. 2016;32(12):1147-1152. PMID: 27655365. DOI: 10.1007/s00383-016-3971-5

16. Markel TA, Proctor C, Ying J, Winchester PD. Environmental pesticides increase the risk of developing hypertrophic pyloric stenosis. J Pediatr Surg. 2015;50(8):1283-1288. PMID: 25783294. DOI: 10.1016/j.jpedsurg.2014.12.009

17. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ, De Laet MH. Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. N Engl J Med. 1992;327(8):511-515. PMID: 1378938. DOI: 10.1056/NEJM199208203270802

18. van den Bunder FA, Derikx JP, Kiblawi R, van Rijn RR, Dingemann J. Diagnostic accuracy of palpation and ultrasonography for diagnosing infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Br J Radiol. 2022;95(1139):20211251. PMID: 36043474. DOI: 10.1259/bjr.20211251

19. Hom J, Lam SHF, Delaney KM, Koos JA, Kunkov S. Vomiting, Pyloric Mass, and Point-of-Care Ultrasound: Diagnostic Test Accuracy for Hypertrophic Pyloric Stenosis-A Meta-Analysis. J Emerg Med. 2023;65(5):e427-e431. PMID: 37722950. DOI: 10.1016/j.jemermed.2023.06.001

20. Gilna GP, Saberi RA, Huerta CT, et al. Laparoscopic versus open pyloromyotomies: Outcomes and disparities in pyloric stenosis. J Pediatr Surg. 2022;57(5):932-936. PMID: 35063253. DOI: 10.1016/j.jpedsurg.2021.12.041

21. Staerkle RF, Lunger F, Fink L, et al. Open versus laparoscopic pyloromyotomy for pyloric stenosis. Cochrane Database Syst Rev. 2021;3(3):CD012827. PMID: 33686649. DOI: 10.1002/14651858.CD012827.pub2

22. Ranells JD, Carver JD, Kirby RS. Infantile hypertrophic pyloric stenosis: epidemiology, genetics, and clinical update. Adv Pediatr. 1999;46:195-229. PMID: 10645466. (Note: Ad libitum feeding meta-analysis widely cited; specific PMID for meta-analysis not retrievable in current search but principle established in multiple subsequent RCTs reviewed in Cochrane 2021)

23. Sivitz AB, Tejani C, Cohen SG. Evaluation of hypertrophic pyloric stenosis by pediatric emergency physician sonography. Acad Emerg Med. 2013;20(7):646-651. PMID: 23781883. DOI: 10.1111/acem.12163

Additional Recent Evidence (2020-2026)

24. Lunger F, Staerkle RF, Beatrice P, Fink L, Baechtold M, Lacher M. Open Versus Laparoscopic Pyloromyotomy for Pyloric Stenosis-A Systematic Review and Meta-Analysis. J Surg Res. 2022;270:234-244. PMID: 35104694. DOI: 10.1016/j.jss.2021.12.042

25. Al-Ansari AN, Maghrabi MA, Al-Zahrani AS, et al. Minimally Invasive Versus Open Pyloromyotomy for Infantile Hypertrophic Pyloric Stenosis: Insights from an Updated Systematic Review and Meta-Analysis. Pediatr Rep. 2025;17(6):124. PMID: 41283384. DOI: 10.3390/pediatric17060124

26. Piotto L, West S, Nataraja RM, Pacilli M. Ultrasound diagnosis of hypertrophic pyloric stenosis - Time to change the criteria. Australas J Ultrasound Med. 2022;25(4):183-188. PMID: 35978726. DOI: 10.1002/ajum.12305

27. Wu P, Zhu H, Zhang X, et al. Single-incision versus conventional laparoscopic pyloromyotomy for pediatric hypertrophic pyloric stenosis: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38(1):127. PMID: 37154949. DOI: 10.1007/s00384-023-04402-z

28. Youssef SB, Ben Khalifa H, Mekki M, et al. Delayed extubation and hypertrophic pyloric stenosis: what are the predictive factors? Front Pediatr. 2025;13:1540435. PMID: 40656205. DOI: 10.3389/fped.2025.1540435

---